The effects of perinatal methamphetamine use on maternal and child outcomes: implications for education among BSN nursing students by Nguyen, Tina
University of Tennessee at Chattanooga 
UTC Scholar 
Honors Theses Student Research, Creative Works, and Publications 
12-2017 
The effects of perinatal methamphetamine use on maternal and 
child outcomes: implications for education among BSN nursing 
students 
Tina Nguyen 
University of Tennessee at Chattanooga, rjx263@mocs.utc.edu 
Follow this and additional works at: https://scholar.utc.edu/honors-theses 
 Part of the Nursing Commons 
Recommended Citation 
Nguyen, Tina, "The effects of perinatal methamphetamine use on maternal and child outcomes: 
implications for education among BSN nursing students" (2017). Honors Theses. 
This Theses is brought to you for free and open access by the Student Research, Creative Works, and Publications 
at UTC Scholar. It has been accepted for inclusion in Honors Theses by an authorized administrator of UTC Scholar. 
For more information, please contact scholar@utc.edu. 
  
The Effects of Perinatal Methamphetamine Use on Maternal and Child Outcomes: 
Implications for Education Among BSN Nursing Students 
Tina Fuong Nguyen 
 
Departmental Honors Thesis 
The University of Tennessee at Chattanooga 
College of Health, Education, and Professional Studies: Nursing 
 
Examination Date: November 11, 2016 
 
 
 
 
 
        
Cherry Guinn, EdD, RN        Susan Thul, DNP, APN, CNM 
Professor of Nursing         Assistant Professor of Nursing 
Thesis Director         Department Examiner 
 
 
 
 
Jenny Holcombe, PhD        Mike Bell 
Assistant Professor of Nursing       Assistant Dean of the UTC  
Department Examiner         Library 
Liaison, Departmental Honors 
Committee
 ii 
Table of Contents 
CHAPTER                                                                                                             PAGE 
Table of Contents……………………………………………………...ii 
Dedication…………………………………..………………..…….....iii 
Abstract……………………………..……………………………...…iv 
Acknowledgements………..…………………………………………..v 
Chapter 1  Introduction………………………………..…………………………..1 
  Statement of the Problem………………………..…………………….2 
  Statement of the Purpose……………………………………..………11  
  Conceptual Framework…………………………………………..…..13 
  Significance of the Study………………………...…………………...17 
Chapter 2 Review of the Literature………………………………………...……19 
  Summary……………………………..………………………………62 
Chapter 3 Methodology……..…………………………………………………..64 
Chapter 4 Results ………………………………………………………...……...75 
Chapter 5 Conclusion…………………………………………………..……….87 
  References……………………………………..……………………..90 
  Appendix A: Informed Consent…………………….…………....…104 
  Appendix B: PRE/POST Surveys………………………...……...….109 
 
 
 
  
iii 
Dedication 
To my father Thanh V. Nguyen and my mother Sunnie T. Nguyen, who surpassed a 
number of life-altering milestones and immigrated to the United States of America in 
order to establish a new foundation upon which their children could pursue a lifestyle 
that they were not given the chance to live, one with opportunities for academic and 
personal success.  
 
 
 
 
 
 
 
 
 
 
 
 iv 
Abstract 
 The implications of methamphetamine use are vast and prevalent in the U.S. 
This epidemic is also well recognized in Tennessee and in Hamilton County. The 
number of men and women that continue to use methamphetamine speaks to the 
importance of this issue. Among these individuals, pregnant women comprise a 
significant portion of female methamphetamine users across the United States. The 
potential complications that can arise for not only a mother but also her child due to 
maternal methamphetamine use pose a much more significant issue. The detrimental 
effects that a child can experience as a result of maternal methamphetamine use 
during pregnancy can potentially lead to ramifications that remain with the child 
throughout the duration of its life. A methamphetamine using woman should be 
aware of the negative complications that methamphetamine use may have on her and 
her child, both in utero and long term. 
 The purpose of this study was to provide educational content on 
methamphetamine, the general effects of methamphetamine use, and the effects of 
perinatal methamphetamine use on maternal and child outcomes. Since limited 
knowledge on this topic is currently made available to nursing students, this project 
took a unique approach to enhancing the practice of nurses by educating nursing 
students so that they are better equipped to recognize methamphetamine users in the 
clinical arena and to increase awareness and knowledge through education in order to 
increase prevention and reduce the rate of disease. PRE/POST surveys were used to 
assess level of knowledge prior to and following an educational presentation of 
methamphetamine content. Teaching was performed through the use of a 
standardized patient role scenario and electronic Prezi presentation.  
 At the conclusion of the study, a comparison of the PRE/POST data illustrated 
an apparent knowledge deficit regarding the effects of perinatal methamphetamine on 
maternal and child outcomes among the third level nursing students enrolled in the 
maternal-childbearing course. Results from the quantitative data indicated a 
significant increase in student knowledge from PRE to POST test (t (33) = -16.94, p < 
.001, d = 3.66). Qualitative data reflected in the students’ written responses showed 
that information acquired from the study is anticipated to be used in future clinical 
practice. Four major themes emerged from the qualitative data: (1) teaching others, 
(2) identification of drug use, (3) patient care, and (4) overall presentation benefit. 
The increased ability to demonstrate these major themes as a result of increased 
knowledge will subsequently enhance the students’ practices as nurses. This was 
expressed through the student’s reflection statements. From the data, it is evident that 
the students displayed a statistically significant increase in knowledge and awareness 
that has the potential to positively influence their professional nursing practices. This 
project is the first of many steps that will hopefully be taken in the future to combat 
the problem surrounding methamphetamine use. Continuous education through the 
use of additional teaching strategies may continue to enhance student knowledge in 
other settings outside the medical arena and among larger populations. Continued 
education can potentially reduce the incidence and prevalence of methamphetamine. 
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Chapter 1 
Introduction 
Like many other illicit drugs, such as cocaine, heroin, and marijuana, 
methamphetamine use continues to be a popular trend among drug users. Within the 
United States, current methamphetamine use has been well established and 
prevalence of use continues to escalate. Methamphetamine is especially notable due 
to the fact that, in contrast to other substances, it is a non-naturally occurring product 
that is synthetically derived from a combination of store-bought chemicals. Aside 
from the ease of accessibility of these products, the effects produced by consumption 
of methamphetamine pose an even greater threat and lend to the detrimental nature of 
this drug.  
Methamphetamine produces a number of effects which are deemed desirable 
to the user and serve as a primary motive for methamphetamine-seeking users. The 
duration of these effects in the body vary as methamphetamine produces both short-
term and long-term effects. However, there are also a number of unfavorable effects 
that occur as a result of methamphetamine consumption. There are a multitude of 
short-term effects as well as long-term effects. In addition to the multitude of short-
term acute effects, there is an even greater number of long-term chronic effects that 
occur as result of methamphetamine use. A lack of treatment for drug use or cessation 
of use altogether can often lead to irreversible damages that could further result in 
death. The detrimental effects of methamphetamine significantly influence not only 
the primary user of the drug but, consequently, all individuals that are also 
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secondarily exposed to the drug and its associated toxins. In addition to the overall 
destructive nature that methamphetamine has on a pregnant woman, for example, 
methamphetamine also leaves a profound impact on the fetus or neonate that is 
unintentionally exposed to the drug.  
Recognizing the growing prevalence of methamphetamine use, particularly 
among pregnant mothers as well as women of childbearing age, The American 
Congress of Obstetricians and Gynecologists (ACOG) has formulated and 
implemented a protocol as a means to combat this issue through establishing methods 
for identification and assessment of methamphetamine use (The American Congress 
of Obstetricians and Gynecologists, 2011). The Association of Women’s Health, 
Obstetric, and Neonatal Nurses (AWHONN) has also implemented recommendations 
regarding identification of methamphetamine users. However, despite their best 
efforts, the number of maternal methamphetamine users and secondarily exposed 
children continues to rise as many are not adequately identified and assessed so that 
sufficient treatment strategies can be developed and implemented. For this reason, 
increased knowledge of the effects of methamphetamine use is necessary. Education 
as a means of health promotion and disease prevention may be a potentially beneficial 
approach to combatting the issue surrounding perinatal methamphetamine before the 
implementation of treatment interventions becomes necessary.  
Statement of the Problem  
The prevalence of methamphetamine use continues to be an escalating 
concern. In contrast to other illicit drugs, methamphetamine is unique in that it is the 
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only substance that can be manufactured from accessible store bought chemicals. 
Methamphetamine use produces numerous acute and short-term effects. The acute 
and short-term effects of methamphetamine include increased attention, decreased 
fatigue, increased physical activity and wakefulness, decreased appetite, heightened 
euphoria and rush, increased respiration, rapid or irregular heartbeat, and 
hyperthermia (National Institute on Drug Abuse, 2012). The chronic and long-term 
effects of methamphetamine are comprised of but are not limited to anxiety, 
depression, confusion, insomnia, paranoia, aggressions, mood disturbances, delusion, 
skin problems, severe weight loss, dental problems, problems with thinking, emotion, 
and memory, progressive social and occupational deterioration, verbal learning 
impairment, motor slowing, suicidal ideation, and visual and auditory hallucinations 
(National Institute on Drug Abuse, 2012). The accumulation of these effects can 
contribute to further complications that include a series of cardiovascular, respiratory, 
neurologic, and psychological related issues which, if not treated, can ultimately lead 
to death.   
In addition to its highly addictive nature, methamphetamine also induces 
immediate drug tolerance. Frequent use of the drug produces an increased tolerance 
to the effects of the drug. Therefore, the user is led to seek out the drug more often 
and in greater quantities. Additionally, the severe negative effects of 
methamphetamine do not always conclude at the point of withdrawal. Withdrawal 
from methamphetamine use often leads to additional physical and psychological 
disturbances. Therefore, increased drug consumption in frequency and amount is 
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often a result because continuous use of the drug allows the user to continue to 
experience the so-called desired effects of the drug while simultaneously avoiding the 
negative effects that can occur as a result of drug withdrawal. On the other hand, this 
only serves as a temporary solution, and in actuality, is no solution at all because 
more frequent and increased use also leads to a greater potential for increased and 
more severe negative effects. The implications of methamphetamine use are profound 
and the aforementioned qualities of methamphetamine are indicative of its 
unfavorable nature and dangerous impact on both secondary and primary users.  
 Worldwide, methamphetamine is second only to marijuana as the most widely 
used illegal drug among 15- to 64-year olds, with a prevalence of 14 to 57 million, or 
0.3% to 1.3% (Gorman et al., 2014). One estimate is that 35 million people 
worldwide regularly use methamphetamine (McGuiness and Pollack, 2008). 
Nationally, while methamphetamine use was once considered an illicit drug use 
phenomenon prevalent in the West and Midwest regions of the United States, the 
geographical divide no longer holds true. The areas in which methamphetamine use 
continues to be the highest include the western states where methamphetamine is the 
third most commonly abused substance after alcohol and marijuana. However, 
methamphetamine use has expanded across the country (Gorman et al., 2014). Most 
recently, the trend has spread east and has established a strong foundation in both the 
Southern and Eastern regions of the United States. According to the United States 
Drug Enforcement Administration’s National Clandestine Laboratory Register 
(2014), there are known methamphetamine laboratories in all 50 states, which implies 
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that the production, use, and sale of this drug is a nationwide trend. The United States 
Drug Enforcement Agency reports that seizure of clandestine methamphetamine 
laboratory sites grew from 7,439 in 1999 to 17,170 in 2004 (U.S. Department of 
Justice, 2006). 
Since 2002, the number of new users of methamphetamine has remained 
steady at about 300,000 per year, doubling the rate of new initiates in the 1990s 
(McGuinness & Pollack, 2008). The lifetime prevalence rate had grown to 12 million 
Americans by 2004 (McGuinness & Pollack, 2008). In 2009, 12.8 million individuals 
aged 12 and older reported using methamphetamine at least once in their lifetime 
(Twomey et al., 2013).  
In 2014, the estimated 1.6 million people aged 12 or older who were current 
nonmedical users of stimulants included 569,000 people who were current 
methamphetamine users. This statistic represents 0.2 percent of the population aged 
12 or older who were current users of methamphetamine in 2014 within the past 
month, while 4.9% of individuals aged 12 and older were reported to have used 
methamphetamine at least once in their lifetime in 2014 (National Institute on Drug 
Abuse, 2012). To date, almost 11 million Americans have tried methamphetamine at 
least once. Of those 10.3 million, 1.3 million used methamphetamine in the last year 
(2015); and 512,000 used it within the last 30 days (Drug Policy Alliance, 2016). 
The number of emergency department (ED) visits also rose as cases related to 
methamphetamine consumption became more prevalent. The number of 
methamphetamine-related visits to emergency departments increased from 67,954 in 
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2007 to 102,961 in 2011, with similar patterns seen for males and females. As 
reported by the Drug Abuse Warning Network in 2011, of the 102,961 total 
emergency department visits involving methamphetamine, methamphetamine was 
documented as the sole and primary substance of abuse among 39,434 cases 
(Substance Abuse and Mental Health Services Administration, 2014). There was an 
increase in emergency department visits from 44,008 in 2007 to 63,092 in 2011 
among males and an increase from 23,942 in 2007 to 39,869 in 2011 for females 
(Substance Abuse and Mental Health Services Administration, 2014). Based on these 
statistics, it is clear that the national incidence of methamphetamine use continues to 
be an issue, though some states are involved with greater incidences of 
methamphetamine use than others. Among these states, Tennessee is considered one 
of the top methamphetamine states in the county.  
Local manufacturing of methamphetamine is second only to cocaine 
trafficking in the state of Tennessee. Clandestine methamphetamine labs in central 
and southeastern Tennessee have reached epidemic proportions. It has been estimated 
that there is at least one methamphetamine lab either located or seized somewhere in 
the state every day (National Substance Abuse Index, n.d.). According to the 
Tennessee Meth & Pharmaceutical Task Force (2016), there have been 11,149 
methamphetamine lab seizures in Tennessee since 1999. In 2015, there were 582 
meth lab sites reported by law enforcement officers in Tennessee. A record amount of 
2,082 methamphetamine lab seizures was recorded in Tennessee in 2010. In 2013, 
Tennessee led the nation in methamphetamine use. Since then, Tennessee has ranked 
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among the top three states for methamphetamine use, even ranking second for the 
highest incidence of methamphetamine use in 2015 (Phillips-Jones, 2015).  
 In Hamilton County alone, the Tennessee Meth & Pharmaceutical Task Force 
reported 104 methamphetamine laboratory seizures out of the 2,082 total seizures in 
2010 (Tennessee Dangerous Drugs Task Force, 2016). Hamilton County was ranked 
4th out of the 95 total counties for the most methamphetamine lab seizures in 2010 
(Tennessee Dangerous Drugs Task Force, 2016). In 2015, five methamphetamine lab 
seizures were reported in Hamilton County. A combined total of 21 seizures were 
reported in the counties surrounding Hamilton County (Tennessee Dangerous Drugs 
Task Force, 2016). Due to the high prevalence of methamphetamine use in Hamilton 
County and its surrounding counties, the city of Chattanooga and Hamilton County 
are currently the home of the Tennessee Dangerous Drugs Task Force, previously 
known as the Tennessee Meth and Pharmaceutical Task Force. The establishment of 
this task force in Chattanooga is a direct response to the fact that methamphetamine is 
a significant concern that has spread far beyond the western region of the United 
States and has established a home in Tennessee, in Hamilton County, and other areas 
surrounding the Chattanooga area.   
 Among methamphetamine users, both worldwide and across the United 
States, women continue to make up a large portion of this population. In contrast to 
other drugs of abuse, more women than men are first-time users and comprise one-
half of those seeking treatment for methamphetamine use (LaGasse et al., 2012). Data 
obtained from treatment centers across the United States in 2003 showed that 45% of 
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patients treated for methamphetamine abuse were women. The continued use of 
methamphetamine among women is especially worrisome because the potentially 
adverse health risks may be greater for women than men.  
The results of a study by Maxwell and Rawson (2014) also revealed that 
women became dependent on methamphetamine sooner than men, initiated 
methamphetamine use in an attempt to alleviate depression, and had higher rates of 
childhood sexual abuse in comparison to men. Similarly, Rawson, Gonzales, Obert, 
McCann, and Brethen (2005) found that young women reported more 
methamphetamine use, became dependent on methamphetamine within a shorter 
period of time, and suffered more adverse effects than did young men. After 
controlling for age and race, more women than men were dependent on 
methamphetamine and identified methamphetamine as their primary drug of choice.  
Overall, methamphetamine use continues to be prevalent among female illicit 
drug users. Maxwell and Rawson (2014) illustrate how methamphetamine appears to 
affect women more greatly than men. This raises alarming concern due to the fact that 
increased incidence of methamphetamine use in women can lead to the potential for 
more severe implications for not only the women but also the children she may bear. 
According to the Center for Disease Control (2012), the childbearing age is 
considered to range from 15-44 years of age, though reports have confirmed the 
possibility of bearing a child as young as 12 years old, with the average age of 
menstruating onset being 12.5 years old (Reference, n.d.).   
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The significance behind the prevalence of methamphetamine use among 
women is due largely in part to the fact that the female population is also inclusive of 
both adolescents of childbearing age as well as women who are already pregnant. 
Women who are pregnant and using methamphetamine are placing their children in 
danger. Increased primary methamphetamine use by the mother leads to increased 
secondary methamphetamine use by her unborn child. Similarly, adolescents who 
could potentially become pregnant are not only harming themselves, but they are also 
putting their future children at risk of secondary exposure. As women and adolescents 
continue to use methamphetamine, their children are ultimately influenced by their 
choice to use methamphetamine.  
In contrast to alcohol, smoking, and marijuana, the amount of literature related 
to methamphetamine use, particularly in pregnancy and among women of 
childbearing age is limited. In addition to the limited amount of literature on the 
effects of methamphetamine use, determining the effects of isolated 
methamphetamine use can be complicated because women who use 
methamphetamine frequently use tobacco, alcohol, and other drugs (The American 
College of Obstetricians and Gynecologists, 2011). The combination of these drugs 
may confound birth outcomes, and therefore, lead to varying results regarding the 
specific effects of methamphetamine. However, while limited, the current available 
literature illustrates a small but, nonetheless, noteworthy number of studies that are 
significant for outlining the isolated effects of prenatal methamphetamine use on 
maternal and neonatal complications during and after pregnancy.  
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The maternal complications that can ensue due to methamphetamine use 
include pregnancy-associated hypertension, preeclampsia, eclampsia, and placental 
abruption. In regards to child outcomes, methamphetamine has been shown to 
increase the risk of birth by cesarean section, premature birth, low birth weight, 
growth restriction, and both fetal and neonatal death. Though limited, current research 
has also shown that these deviations can lead to long term deficits that affect the 
cognitive, motor, physical, and neurobehavioral development of the child.   
Given the potential risks to maternal, fetal, and infant health and well-being 
with methamphetamine use in pregnancy, identification of use is important, according 
to the American College of Obstetricians and Gynecologists (ACOG) as well as The 
Association of Women’s Health, Obstetrics, and Neonatal Nurses (AWHONN), 
which states that “early identification...of women with substance use disorders and/or 
dependence is a critical component of preconception and prenatal care and is 
important for supporting healthy birth outcomes” (The Association of Women’s 
Health, Obstetric and Neonatal Nurses, 2015). In addition to identification of 
methamphetamine use, adequate assessment is vital guiding the appropriate method 
of treatment and, thus, ensuring that sufficient patient care is being provided.  
The multitude and severity of the outcomes due to primary and secondary 
methamphetamine use and exposure indicate a heightened demand for the provision 
of education and awareness among current and future health care professionals 
regarding this pertinent topic. Considering the fact that methamphetamine use in 
pregnancy continues to be a significant problem, the focus of educational awareness 
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relating to maternal methamphetamine use in pregnancy must be centralized on the 
deleterious effects of primary and secondary methamphetamine exposure. Increased 
knowledge of the effects of methamphetamine allows health care professionals to 
more successfully recognize and assess methamphetamine users. 
Statement of the Purpose 
The purpose of this project is to educate and prepare baccalaureate nursing 
students regarding the effects of methamphetamine on maternal and child outcomes. 
They will be educated on how to identify individuals who are using 
methamphetamine or exposed secondarily. Since the amount of knowledge made 
available on this particular topic to nursing students is very limited, increasing 
familiarity and understanding on specific information regarding methamphetamine 
will increase their awareness of methamphetamine use and the effects of use on their 
patients. Although nursing students may pursue different paths within the nursing 
profession, they will be aware, in any case, of the detrimental effects of 
methamphetamine on a mother and her child and will therefore be prepared to 
properly identify methamphetamine use and to disseminate this information to others. 
Thus far, the recommendations set forth by ACOG and AWHONN serve as 
the sole standard for identification relating to methamphetamine use. While they are 
effective, they, alone, have not been successful in treating the continued prevalence of 
methamphetamine use. A proactive approach to addressing this problem is increasing 
education that is directed towards the negative effects of methamphetamine on 
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maternal and child outcomes and the signs and symptoms that are manifested in 
primary and secondary methamphetamine users. 
Due to the danger that methamphetamine use and exposure poses, particularly 
during pregnancy, the focus of education should be directed at educating nurses on 
the effects of methamphetamine use as well as signs and symptoms that are indicative 
of methamphetamine use. Nurses are on the frontline of resistance to 
methamphetamine abuse in the United States and, through the education and 
knowledge they possess regarding various health-related clinical and nonclinical 
functions, assume key roles in protecting families and children from this drug within 
the health care setting.  
In the perinatal setting, nurses carry the responsibility of providing holistic 
patient-centered care and taking into consideration what is best for both the expecting 
mother and child through every clinical decision and action. By educating and 
empowering nurses on avenues for identification through increased knowledge of 
methamphetamine abuse, nurses can continue to succeed in providing patients with 
the optimal care they deserve by educating them. Nurses who are keenly aware of the 
adverse maternal, fetal, and neonatal effects of methamphetamine will be able to 
identify qualities characteristic of methamphetamine use and exposure and utilize this 
knowledge to identify methamphetamine use. Nurses can, in turn, spread their 
knowledge by educating other health care professionals, and especially, the patients 
that they encounter. As a result, they are not only enhancing their practice as nurses, 
but also contributing to the cause to cease methamphetamine use.  
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Conceptual Framework 
Due to the heightened prevalence of methamphetamine use among pregnant 
women and the associated detrimental maternal, fetal, and neonatal complications, 
there is a greater demand for the development of strategies in order to combat 
methamphetamine use altogether. A possible approach to reducing this issue is 
through the use of teaching and education. The issue surrounding the prevalence of 
methamphetamine and methamphetamine-related complications can be examined 
through Dorothea Orem’s theoretical framework of nursing. Orem, a nursing theorist, 
developed the Self-Care Deficit Nursing Theory, which rests upon the ideas that 
people innately desire self-care agency; there is a need for nursing based on the health 
deviations of a person at any given time; the needs of the patient mold the 
responsibilities of the nurse in order for the nurse to adequately and effectively 
address the person’s needs; and the nurse has a role to help the person to overcome or 
adapt to the self-care deficit (“Theory-Based Nursing Practice”, n.d.).  
The basis of Orem’s model is centered on the theory of self-care, which 
explains and develops the reason why individuals require nursing care. Self-care, 
which is defined as a “human regulatory function that persons must perform for 
themselves in order to maintain life”, is a concept that must be learned and 
deliberately performed (“Theory-Based Nursing Practice”, n.d.). The ability to 
engage in self-care dependent-care is affected by a person’s limitations in knowing 
what to do, when to do it, and how to do it, according to Orem. The ability of a 
person to successfully perform self-care is influenced by individualized self-care 
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requisites, or the “requirements necessary for maintaining functional integrity, health, 
and well-being” (“Theory-Based Nursing Practice”, n.d.). Self-care requisites are 
based on the assumptions that human beings have common needs for the intake of 
materials necessary to sustain and maintain life; human development from in utero to 
mature adult requires action to maintain conditions to promote growth and 
development at each period of the life cycle; and deviation from normal structure and 
function and well-being requires action to prevent occurrences and action to control 
the effects of the deviation (“Theory-Based Nursing Practice”, n.d.). If a person lacks 
the capacity or is unable to meet his or her self-care requisites at any point in time, 
nursing care is needed. 
Nursing is not only a public declaration of commitment to care for 
individuals, groups, and communities, but is also comprised of both teaching and 
learning. Nursing consists of responsibilities and obligations that are vast and vary 
greatly depending on the patient’s circumstance. Along with being contingent upon 
the patients’ self-care deficits, two components that are essential to the nature of the 
helping service provided by nurses are nursing systems and nursing agency. 
According to Orem, nursing systems are “series and sequences of deliberate practical 
actions of nurses performed at times in coordination with actions of their patients to 
know and meet components of their patients’ therapeutic self-care demands and to 
protect and regulate the exercise or development of patients’ self-care agency” 
(“Theory-Based Nursing Practice”, n.d.). The idea of nursing systems is carried out 
through the exercise of nursing agency. The concept of nursing agency, or “the skills 
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and life experiences that nurses have gained through years of education and practice 
that they use to effectively treat patients,” arises when there is a need for nursing 
(“Theory-Based Nursing Practice”, n.d.). In considering the concepts of nursing 
systems and nursing agency, the nurse possesses the personal qualities and skills to 
address a person’s self-care needs while doing so effectively, prudently, and 
professionally.  
In order for nurses to address a person’s self-care deficits and provide safe, 
effective, and quality care, the nurse must be competent in various areas. The nurse 
must possess the knowledge to identify and analyze a particular situation, determine 
what interventions must be implemented and develop a plan of care while 
concomitantly adhering to the facility policies and standards of care. To do so, the 
nurse must have acquired optimum knowledge and information of the nursing process 
so that these functions can be carried out. A lack of knowledge can negatively affect 
the nurse’s ability to adhere to, carry out, and maintain the nursing agency and system 
that patients deserve and that are relevant to the patient’s self-care needs. Since self-
care requisites are highly individualized and specific to each patient, optimal 
knowledge can assist the nurse in how to approach the nursing care for the maternal 
methamphetamine user, and therefore, properly carry out the appropriate nursing 
systems and nursing agency. Acquisition of education allows the nurse to provide 
optimal care for the patient. Optimal care includes possessing the knowledge of the 
overall negative ramifications of methamphetamine use and the severe implications of 
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maternal methamphetamine use on both the mother and her child and relaying this 
information to patients. 
The effects of methamphetamine can significantly interfere with an 
individual’s ability to adequately meet his or her self-care requisites or comprehend 
that self-care requisites need to be met. As a result, nursing becomes an essential 
factor so that the self-care requisites of a methamphetamine user are addressed. The 
conclusion that a person has self-care needs or is unable to carry out his or her self-
care requisites is determined by a systematic assessment. The assessment confirms 
the presence of a therapeutic demand and establishes the needs for an appropriate 
plan of care. Greater proficiency of assessment skills allows the nurse to carry out his 
or her clinical responsibilities more optimally and successfully.   
Nurses must should be knowledgeable of the effects of methamphetamine and 
identify the signs and symptoms of methamphetamine use because proper 
identification guides the nurse’s mode of response to the patient.  Possession of this 
knowledge nurses also enables the nurse to further educate methamphetamine using 
patients with current or potential pregnancies. In turn, patients will be better equipped 
to care for themselves with the best knowledge possible, which includes making more 
informed choices and understanding the consequences of their current choices.  
Therefore, in Orem’s view, lack of knowledge relating to the effects of 
methamphetamine and identification of the methamphetamine user would be 
identified as serious obstacles, resulting in the hindrance of the nurse’s capacity to 
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perform and provide adequate nursing care and address an individual’s self-care 
needs.  
Significance of the Study 
Current resources targeted to identifying and assessing maternal 
methamphetamine use in pregnancy have not been sufficient to treat the cause and 
lead to long term reductions in incidence. Due to its highly addictive nature, the high 
prevalence of methamphetamine use continues to exist. Because methamphetamine 
use negatively affects not only the primary consumer but also secondarily exposed 
individuals, additional efforts must be established to more adequately identify 
maternal methamphetamine users who are currently pregnant or may potentially 
become pregnant so that the appropriate intervention and treatment methods can be 
implemented as well as the proper teaching. 
The objective of this project is to provide specific information on the effects 
of general methamphetamine use and the detrimental impacts of methamphetamine 
on both a mother and her child in pregnancy. An examination of the literature 
illustrating the acute and chronic effects of maternal methamphetamine use on a 
woman and her child demonstrates that the complications that can arise as a result of 
methamphetamine use can last beyond the period of pregnancy and can affect a 
mother and her child indefinitely.  
Because nurses play a vital role as health care professionals when caring for 
mothers and children in the perinatal setting, it is essential to educate nurses on the 
issue surrounding maternal methamphetamine use in pregnancy and on avenues for 
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proper identification and teaching. Increasing provision of education among nurses 
enhances the overall practice of nurses by preparing them to adequately identify 
methamphetamine use and, ultimately, to engage in opportunities for teaching more 
frequently.  
In this project, information will be presented to the nursing students in the 
third level of study within the School of Nursing at the University of Tennessee at 
Chattanooga (UTC). These students are studying the role of the nurse when caring for 
families expecting children. The objective of this project is to educate baccalaureate 
nursing students, who will later become registered nurses, so that they are well 
equipped to apply this knowledge through identification of use and patient teaching. 
Furthermore, they will be able to use this knowledge to educate their colleagues, and 
most importantly, patients on the negative implications of methamphetamine use in 
pregnancy.  
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Chapter 2 
Review of the Literature 
Methamphetamine is a highly addictive central nervous system stimulant drug 
whose chemical structure is similar to that of amphetamine. Stimulants comprise a 
class of drugs that are known to enhance mood, increase feelings of well-being, 
increase energy levels, and stimulate alertness (National Institute on Drug Abuse, 
2016). Methamphetamine comes in several forms, including powder, crystal, rocks, 
and tablets. Regular methamphetamine is a pill or white, odorless, bitter-tasting 
powder that easily dissolves in water or alcohol. Crystal methamphetamine takes the 
form of glass fragments or shiny blue-white “rocks” of various sizes (Substance 
Abuse and Mental Health Services Administration, 2014). 
Otherwise known as “meth” or by various street names such as “Crank”, 
“Chalk”, “Crystal”, “Fire”, “Glass”, “Go Fast”, “Ice”, “Tina”, or “Speed”, 
methamphetamine is classified as a Schedule II drug, meaning it has a high potential 
for abuse and limited medical use (National Institute on Drug Abuse, 2016). It is 
legally available through a prescription that cannot be refilled. Methamphetamine, 
which was developed in the early 20th century from its parent drug, amphetamine, 
was originally used in nasal decongestants and bronchial inhalers (National Institute 
on Drug Abuse, 2012). It was also widely available to treat a range of disorders, 
including attention deficit hyperactivity disorder (ADHD), obesity, narcolepsy, 
depression, obesity, and alcoholism (Drug Policy Alliance, 2016). Pharmaceutical 
methamphetamine is still available legally to solely treat obesity, narcolepsy, and 
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ADHD, but is infrequently prescribed due to the high potential for abuse and 
addiction. In these cases, the prescribed dose is far lower than those typically abused.  
Production and Manufacture of Methamphetamine 
Unlike drugs such as marijuana, cocaine, and heroin, which are derived from 
plants, methamphetamine is the only illicit drug that can be manufactured easily from 
store bought chemicals. The most common ingredient in methamphetamine is 
pseudoephedrine or ephedrine, commonly found in cold medicine. Through a cooking 
process, the pseudoephedrine or ephedrine is chemically converted into 
methamphetamine. Additional ingredients that are essential for the process of making 
methamphetamine can include: ether, paint thinner, Freon ®, acetone, anhydrous 
ammonia, iodine crystals, red phosphorus, drain cleaner, battery acid, and lithium 
(United States Drug Enforcement Administration, 2014). 
 Methamphetamine is often manufactured or “cooked” in laboratories. Most of 
the methamphetamine manufactured in the United States come from “super labs”, or 
large illegal laboratories that produce the drug in large quantities (United States 
Department of Justice Archive, n.d.). Many of these laboratories are not sophisticated 
operations and do not require elaborate chemistry equipment. Those who produce 
methamphetamine usually do not possess any chemistry training. While cooking 
methamphetamine is relatively simple, it is a highly dangerous and toxic process.  
Physiological Mechanism of Methamphetamine  
 Methamphetamine is a central nervous system stimulant of the sympathetic 
nervous system. Methamphetamine belongs to a class of drugs referred to as 
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amphetamines. Amphetamines enhance the release of catecholamines, increasing 
intrasynaptic concentration levels of norepinephrine, dopamine, and serotonin. 
Methamphetamine may enhance synaptic catecholamine levels by inhibiting 
monoamine oxidase, the enzyme responsible for the oxidation of norepinephrine and 
serotonin. The psychoactive and potential neurotoxic effects from prolonged or high 
doses of methamphetamine may occur due to the following mechanisms that increase 
the synaptic or extracellular levels of these monoamines, primarily dopamine: 1) 
displacement of monoamines from synaptic vesicles to the cytosol; 2) reverse 
transport of neurotransmitters through plasma membrane transporters and through 
blocking the activity of dopamine transporters as well as decreasing the expression of 
these transporters at the cell surface; 3) increased activity and expression of tyrosine 
hydroxylase; and 4) inhibition of monoamine oxidase (Wouldes et al., 2014).  
According to the National Institute on Drug Abuse (2012), 
methamphetamine’s mechanism of action is to block reuptake of both dopamine and 
norepinephrine, as well as promote the release of dopamine into the synaptic cleft 
leading to high levels of the chemical in the brain, a common mechanism of action for 
most drugs of abuse. Dopamine is involved in reward, motivation, the experience of 
pleasure, and motor function. Methamphetamine’s ability to rapidly release dopamine 
in reward regions of the brain produces a sense of increased alertness and intense 
euphoria.  
The result of methamphetamine use is general excitation of the central 
nervous system, which accounts for the “desired” effects of increased alertness, 
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euphoria, and anorexia. However, higher concentrations of dopamine in the synapse 
may be toxic to nerve terminals. Therefore, the chronic use of methamphetamine may 
lead to long lasting functional impairments in the monoamine systems in the brain, 
particularly at sites involving dopamine (McGuiness & Pollack, 2008).  
Effects of Methamphetamine Use 
Methamphetamine has a longer half-life than a majority of other drugs, such 
as cocaine, and has additional mechanisms of action in the central nervous system. 
The half-life (or time required for half the quantity of the drug to be metabolized or 
eliminated by normal biological processes) of methamphetamine is approximately 
twelve hours, whereas the approximated half-life of cocaine is one hour (American 
Congress of Obstetricians and Gynecologists, 2011). Due to its prolonged half-life, 
methamphetamine continues to be a commonly sought out drug. On the other hand, 
while an extended half-life is a desirable quality to the individual abusing it, the 
length of time that the drug is present in the body also equates to the significant 
implications that it can have on the user and those exposed to it. 
Methamphetamine can be taken by a variety of methods, including smoking, 
snorting, injecting, ingestion, or by the anal route. When methamphetamine is 
smoked or injected, the user experiences an intense rush that lasts only a few minutes. 
Snorting or oral use of the drug produces euphoria but not the intense high that is 
experienced if it is smoked or injected. The effects of snorting are felt within three to 
five minutes and within fifteen to twenty minutes when ingested orally. 
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The effects of methamphetamine on the user are well-established. Like 
amphetamine, methamphetamine causes increased activity and talkativeness, 
decreased appetite, and a heightened sense of well-being or euphoria. However, what 
differentiates methamphetamine from amphetamine is that, in comparable doses, 
much greater amounts of methamphetamine enter the brain, making it a more potent 
stimulant. When taken, methamphetamine results in the development of both short-
term and long-term effects. 
Methamphetamine use can produce rapid effects as a result of the release of 
dopamine, norepinephrine, and serotonin. The immediate and short-term effects of 
methamphetamine may include: increased attention, increased energy and decreased 
fatigue, increased physical activity and wakefulness, decreased appetite, heightened 
euphoria and rush, increased respiration, rapid or irregular heartbeat, and 
hyperthermia (National Institute on Drug Abuse, 2012). Methamphetamine use is also 
associated with increased libido and sexual pleasure as well as high-risk sexual 
behavior. Prolonged sleep and mild dysphoria occur as the drug’s effects wear off 
(Winslow, Voorhees, & Pehl, 2007). Additional adverse effects due to acute 
methamphetamine exposure may also include: anorexia, anxiety, hypertension, 
psychosis, renal failure, rhabdomyolysis, seizures, sexually and parenterally 
transmitted infections, stroke, and trauma (Winslow, Voorhees, & Pehl, 2007). 
 In addition to the immediate and short-term impact of methamphetamine, 
long-term use of methamphetamine also has a multitude of damaging effects. Chronic 
methamphetamine abusers experience anxiety, depression, confusion, insomnia, 
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paranoia, aggressions, mood disturbances, delusions, skin sores (due to scratching), 
severe weight loss, dental problems, problems with thinking, emotion, and memory, 
progressive social and occupational deterioration, verbal learning impairment, motor 
slowing, suicidal ideation, visual and auditory hallucinations (Substance Abuse and 
Mental Health Services Administration, 2014).  
Distinctive changes also occur in the physical appearance of long-term 
methamphetamine users, producing an aging effect. A common hallucination 
experienced by meth users is the so-called crank bug.  The user gets the sensation that 
there are insects creeping on top of, or underneath, the skin. The user will pick at or 
scratch the skin, attempting to get rid of the imaginary bugs. This scratching can 
create open sores that may then become infected. Furthermore, methamphetamine 
reduces the amount of protective saliva around the teeth. Methamphetamine users 
also consume carbonated soft drinks in excessive number, they tend to neglect 
personal hygiene, and grind their teeth and clench their jaws. The combination of 
such actions lead to what is commonly called “meth mouth” (National Institute on 
Drug Abuse, 2016). “Meth mouth” refers to the physical changes that can occur as a 
result of methamphetamine use and consists of significant tooth decay and 
periodontal loss. 
Without complete cessation, successful treatment, and recovery, the adverse 
effects of methamphetamine on the brain cannot be diminished or reversed, which 
can result in potentially irreversible neuronal changes (Winslow, Voorhees, & Pehl, 
2007). These changes can produce neurologic and psychiatric symptoms which are 
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most likely caused by dopamine depletion. Methamphetamine can also cause a 
variety of cardiovascular related issues including elevated heart rate, irregular heart 
rhythms, and increased blood pressure. High doses can elevate body temperature to 
dangerous, and sometimes lethal, levels and can cause convulsions and death (U.S. 
Department of Justice Drug Enforcement Administration, n.d.).  
One of methamphetamine’s most devastating effects is addiction. Addiction to 
methamphetamine can occur quickly, as repeated use lowers the brain’s ability to 
manufacture dopamine, leading to increased cravings for the drug (Hohman, Oliver, 
& Wright, 2004). Despite the desire to withdraw from using the drug, withdrawal 
from methamphetamine can cause additional adverse effects such as depression and 
apathy. These are symptoms that most users wish to avoid, thus leading the already 
addicted individual to continuously seek out the drug.  
Methamphetamine also induces tolerance, which leads to consumption of 
increased doses in order to produce the same effect. To increase its effects, users may 
take higher doses of the drug, take it more frequently, or change their method of 
intake, such as snorting or injecting it. Because the effects produced my 
methamphetamine do not last long, users of the drug often take the drug repeatedly, in 
a “binge and crash” pattern (National Institute on Drug Abuse, 2016). 
Continued methamphetamine use can cause effects that persist even after 
cessation of drug usage. Because methamphetamine has a significantly longer half-
life in the body than other stimulants, such as cocaine, it leads to prolonged stimulant 
effects as well as a more intense and protracted withdrawal experience (National 
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Institute on Drug Abuse, 2013). As previously mentioned, dopamine and serotonin 
are neurotransmitters associated with feelings of well-being, key components in the 
reward center of the brain. Ingesting methamphetamine boosts both dopamine and 
serotonin levels, producing temporary feelings of well-being (White, 2002). When the 
effect of the methamphetamine ends, levels of these neurotransmitters drop 
precipitously causing two distinct phases of methamphetamine withdrawal: acute 
withdrawal and subacute withdrawal (McGregor et al., 2005). The acute phase is 
marked by increases in sleeping and appetite as well as depression-related symptoms. 
However, anxiety, irritability, and craving of methamphetamine also may occur. After 
about three days of the acute phase, a “crash” period has been described that involves 
sleeping excessively (McGregor et al., 2005). Withdrawal is further complicated by 
insomnia on the sixth day that lasts until the twentieth day of methamphetamine 
abstinence. Other signs and symptoms of withdrawal include somnolence, trouble 
sleeping, anger, nervousness, depression, anxiety, irritability, inability to concentrate, 
psychomotor slowing, paranoia, increased appetite, and a continuous strong craving 
for methamphetamine (National Institute on Drug Abuse, 2016). 
As a powerful stimulant, methamphetamine can also cause death, which can 
ensue from cardiovascular collapse, a heart attack, or stroke that results from the 
drug’s effects on norepinephrine, a neurotransmitter that raises heart rate and blood 
pressure and constricts blood vessels. Myocardial infarction, respiratory failure, 
stroke, cardiomyopathy, and hepatitis have also been reported as a result of chronic 
methamphetamine exposure (Winslow, Voorhees, & Pehl, 2007). Due to the 
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tolerance, reverse-tolerance, or redistribution, the fatal concentration of 
methamphetamine in the blood varies among reports and ranges from 0.5 to 41 mg/L 
(Sakai, Iwadate, Maebashi, Matsumoto, & Takasu, 2015). The fact that the fatal 
concentration of methamphetamine is not concretely defined and that 
methamphetamine abusers are not aware if the amount they consume is substantial 
enough to produce death lends to the drug’s dangerous nature. 
Effects of Secondary Methamphetamine Exposure  
In addition to the direct effects that methamphetamine can have on the user, 
there are also significant secondary effects on an individual who is not using 
methamphetamine, but is exposed to methamphetamine. Manufacturing of 
methamphetamine can expose both primary and secondary users to toxic chemicals 
and fumes through absorption, inhalation, or ingestion. Methamphetamine 
laboratories generate highly explosive gases that place all individuals at an increased 
risk of injury or death.  
Fumes generated by the production of methamphetamine are breathed in 
during production both day and night. Residue that is present in food is consumed and 
the byproducts of methamphetamine are absorbed from every surface within the 
home (Hohman, Oliver, & Wright, 2004). The acute health effects of exposure to 
methamphetamine production can include burning of the eyes and skin, headaches, 
dizziness, nausea, and respiratory distress (Hohman, Oliver, & Wright, 2004). The 
long-term chronic effects of inhalation or contact with the chemicals used in 
manufacturing methamphetamine are not known, although there have been reports of 
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severe lung disease in police officers involved in methamphetamine laboratory 
seizures (Hohman, Oliver, & Wright, 2004). Such disease is a function of the toxic 
effect on the lungs of the acid chemicals used in the process of producing 
methamphetamine. Some of the catalysts used in the making of methamphetamine 
also include toxic heavy metals that can cause severe kidney and neurologic damage 
if ingested in sufficient quantities (Hohman, Oliver, & Wright, 2004). Other reported 
side effects from the precursor chemicals utilized to manufacture methamphetamine 
include liver and kidney disease, cancers such as lymphomas and leukemias, bone 
marrow suppression resulting in anemia, and increased risks of infection (Hohman, 
Oliver, & Wright, 2004). It is clear, based on these established findings, that 
methamphetamine is equivalently harmful for both the primary and secondary 
methamphetamine user.  
Prevalence of Methamphetamine Use Among Pregnant Women/Adolescents 
As evidence confirms, there continues to be a large number of pregnant 
women and adolescents who use methamphetamine. Current research and statistics 
illustrate that substance use by pregnant women continues to be a serious public 
problem. Colliver, Kroutil, Dai, and Gfroerer (2006) report that roughly 19,000 
pregnant women across the United States use methamphetamine annually. Among 
29,494 women giving birth in California, the Infant Development, Environment, and 
Lifestyle (IDEAL) study found that 206, or 0.7%, of the total number of women 
reported using an amphetamine during pregnancy (Liles et al., 2012). Liles et al. 
(2012) also found that among 1,632 mothers giving birth in areas known for high 
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methamphetamine use, 5.2% of mothers were documented to have used 
methamphetamine during pregnancy (Liles et al., 2012). This percentage equates to 
84 women who used methamphetamine during pregnancy. Similarly, a large-scale 
study on methamphetamine use in pregnancies across the United States indicated that 
at some point during their pregnancy, 5.2% of these women used methamphetamine 
(Arria et al., 2006). 
In addition to the previously mentioned data, which delineates the prevalence 
of methamphetamine use among pregnant women in the United States, additional 
studies display statistics regarding the prevalence of treatment admissions among 
pregnant women. This data is comparably significant for it illustrates the continued 
occurrence of methamphetamine use among this particular demographic. According 
to additional studies regarding maternal methamphetamine use, in 1994, 
methamphetamine accounted for 8% of pregnant women who were admitted for 
substance abuse. This percentage rose significantly by 2006, when methamphetamine 
accounted for 24% of admissions by pregnant women to federally funded substance 
abuse treatment centers the United States (Terplan, Smith, Kozloski, & Pollack, 
2009). In 2010, the percentage of pregnant women seeking treatment for 
methamphetamine abuse increased yet again, doubling to 46%, according to the 2010 
National Survey on Substance Abuse and Health.  
According to the Substance Abuse and Mental Health Services Administration 
(SAMHSA), pregnant teenage admissions for methamphetamine abuse had more than 
quadrupled from 4.3% of admissions in 1992 to 18.8% in 2007. The Substance Abuse 
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and Mental Health Services Administration also found that not only had treatment 
facilities across the U.S. seen the highest number of pregnant teenage admissions in a 
decade, but the largest increase in the type of substance abuse being treated was 
caused by methamphetamine use (Good et al., 2010). A large fraction of this statistic 
is divided among some of the highest methamphetamine using states in the United 
States, including Tennessee. 
Tennessee’s population of pregnant women comprise a significant portion of 
the methamphetamine using women across the United States. Statistics provided by 
the National Substance Abuse Index for the state of Tennessee, which is currently one 
of the highest ranked states in methamphetamine use, illustrated that out of 14,627 
drug users identified in the state, 84.3% of drug individuals between the ages of 12 
and 45 were methamphetamine users (National Substance Abuse Index, n.d.). In 
addition, 25.2% of the 14,627 individuals were female methamphetamine users 
(National Substance Abuse Index, n.d.). In 2014, 44.8% of people in Tennessee who 
were admitted for methamphetamine abuse treatment were women. This corresponds 
to 478 of 1069 total individuals (Center for Behavioral Health Statistics and Quality, 
Substance Abuse, and Mental Health Services Administration, 2015). For the 14th 
year in a row, state figures show that Tennessee is on pace for more drug-dependent 
births than the year before — approaching 1,000 out of the state's 80,000 annual 
births (Gonzalez and Boucher, 2015). This conclusion is highly significant for it 
further confirms that the prevalence of methamphetamine use in pregnancy continues 
to burden the United States, the incidence of methamphetamine use is well 
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recognized far beyond the western United States, and relevant for the purpose of this 
paper, has become a local concern.  
Demographic and Psychosocial Characteristics of Mothers Using 
Methamphetamine During Pregnancy 
Just as the clinical effects of methamphetamine are well-known, the 
demographic characteristics that exist among methamphetamine using mothers have 
also been recognized and are consistent among maternal methamphetamine users.  
Research suggests that methamphetamine using mothers are more likely to 
receive fewer prenatal care visits than non-methamphetamine using mothers (Liles et 
al., 2012). A study by Gorman et al. (2010) displayed results that support these 
claims, for more than two-thirds of methamphetamine-abusing mothers reported 
having fewer than five prenatal appointments during their pregnancies, compared to 
10% of mothers from the control group (Good et al., 2010). Gorman et al. (2014), 
Nguyen et al. (2010), and Smith et al. (2008) also found that methamphetamine users 
are also more likely to have fewer prenatal care visits and begin prenatal care at a 
later gestational age when compared with mothers unexposed to methamphetamine. 
Equally, the demographic characteristics of the sample population in the study by 
Wouldes et al. (2015) displayed that the methamphetamine-exposed group had 
mothers with no partner at birth and who presented later in gestation for prenatal care. 
In addition to the claim that methamphetamine using mothers receive delayed 
prenatal care, the population of methamphetamine using mothers in a study by Shah 
et al. (2011) were found to be less likely to receive prenatal care at all. Likewise, 
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Smith et al. (2010) found that the women in the methamphetamine exposed group of 
their study were less likely to have attended prenatal care visits than the comparison 
group. Based on these studies, it is evident that methamphetamine use during 
pregnancy often affects the timing during which mothers seek out prenatal care. In 
some cases, mothers fail to seek prenatal care at all. This, as a result, can negatively 
affect the child as well as the mother using methamphetamine.  
In addition to receiving delayed or no prenatal care at all, methamphetamine 
using mothers are more likely to be younger, poorer, single, and less educated than 
non-methamphetamine using mothers at their child’s birth. Mothers in the 
methamphetamine group of a study by Nguyen et al. (2010) were younger and more 
likely to have low socioeconomic status, no partner, and have fewer than twelve years 
of education as compared to the unexposed group. These findings are reinforced by 
Gorman et al. (2014), whose population sample included 12% of methamphetamine 
using mothers who were married versus 46% of the control group’s mothers who 
were married. A higher percentage of methamphetamine using mothers were also 
unemployed in comparison to the control group.  
Smith et al. (2008) and LaGasse et al. (2012) also found, in their studies, that 
relative to the comparison group, the methamphetamine-exposed group was more 
likely to have a lower socioeconomic status and to be without a partner (Smith et al., 
2008). Similarly, demographics collected at birth and 36 months of age in the study 
by Liles et al. (2012) showed that the comparison mothers had a higher income at 
their child’s birth and were more likely to be married or living with a partner than 
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methamphetamine using mothers at both visits. 
 Grant and her associates (2010) screened a cohort of 84 women exposed to 
methamphetamine use during pregnancy and enrolled 92 women to serve as controls. 
Compared with the control group, women in the methamphetamine group were of 
lower socioeconomic status and lacked a partner (57% vs. 36%). This finding is also 
supported by Diaz et al. (2014), though they found no differences in educational level 
or maternal age. Good et al. (2010), who aimed to report the demographic 
characteristics of methamphetamine-exposed pregnancies compared with control 
patients, confirmed the findings of previously mentioned studies, showing that 
methamphetamine users were more likely to be unmarried and unemployed. They 
also had an 11th grade education or less, and were less likely to receive prenatal care, 
a characteristic confirmed by Gorman et al. (2014), Liles et al. (2012), Shah et al. 
(2011), Smith et al. (2008), and Nguyen et al. (2010).  
 Methamphetamine using mothers have also been found to be more likely to 
have ongoing legal difficulties and be involved in domestic violence than a non-
methamphetamine using group (Liles et al., 2012). Liles and colleagues enrolled 212 
mother-child dyads as a subset of the participants in the Infant Development, 
Environment, and Lifestyle (IDEAL) Study, an ongoing longitudinal study. The 
mother-child pairs were followed from birth until 36 months. Of the 412 participants 
in the study, only 212 biological mothers maintained continuous custody of their 
children from birth to 36 months (137 comparison mothers and 75 prenatally 
methamphetamine using mothers). The primary reason was due in large part to 
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physician’s mandatory reporting of the mother’s illicit drug use during pregnancy, 
resulting in the involvement of Child Protective Services. The comparison group was 
found to be larger since this group was more likely to have continuous custody of 
their child at 36 months than the methamphetamine using group. This is an additional 
characteristic that often differentiates methamphetamine using mothers from non-
methamphetamine using mothers and is further supported by Smith et al. (2008), 
whose study showed that 40% of methamphetamine using mothers lost custody of 
their babies who were then placed in foster care, Child Protective Services, adoption, 
or were receiving care from another individual.  
Similarly, Shah et al. (2011) concluded from their study that 
methamphetamine-exposed infants were more likely to be referred to Child Protective 
Services. Comparable to the three aforementioned groups of researchers, Brunk 
(2004) also demonstrated, as a result of his study, that maternal methamphetamine 
use in pregnancy was correlated with more referrals to Child Protective Services at 
discharge (51% vs. 6%) with 26% (vs. 3%) of newborns not placed with their 
mothers. Based on these findings, maternal methamphetamine use is a common 
predictor of disruption in custody and placement of children into out-of-home settings 
(McGuinness and Pollack, 2008). 
 Building upon the claims made by Liles et al. (2012), Twomey et al. (2013) 
also illustrated, through their study, that the psychological adversities identified 
among methamphetamine using pregnant women include involvement in the legal 
system. In addition, Twomey et al. (2013) also found that maternal drug use is in 
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general associated with a number of adverse environmental risk factors that include 
domestic violence, other forms of abuse and violence, and limited social support. 
Likewise, Good et al. (2010 and Gorman et al. (2014) reported that methamphetamine 
using women were likely to experience increased incidences of domestic violence 
compared to the control group. In the study by Good et al. (2010), almost one-fourth 
of methamphetamine using mothers reported domestic violence. 
 Additional evidence supports the claim that maternal methamphetamine use is 
correlated to various psychological implications. Psychiatric disorders are prevalent 
among methamphetamine pregnant women and have been reported to be even more 
common than among women who use other drugs such as cocaine, marijuana, 
opiates, tobacco, or alcohol (Oei, Abdel-Latif, Clark, Craig, & Lui, 2010). Coexisting 
substance abuse and psychiatric disorders, such as major depression, can interfere 
with competent parenting capacities, which can in turn adversely impact child 
behavior (Hans, 1999).  
 Liles et al. (2012) conducted a study to examine the association between 
methamphetamine use during pregnancy and maternal parenting stress, maternal 
depression, and perceived child behavior problems. From their results, Liles et al. 
(2012) found that both at birth and at the child’s 36-month visit, methamphetamine 
mothers reported significantly higher parenting stress scores and lower quality of life 
perceptions than comparison mothers. Further, a comparison of depression scores 
between the methamphetamine using mothers and comparison mothers showed that 
methamphetamine using mothers reported statistically significant higher levels of 
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depressive symptoms than comparison mothers, a finding that supports that of Heiss, 
Goldberg, and Dion (2010), who also concluded that pregnant methamphetamine 
using mothers are often at risk for depression.  
 In their study, Heiss, Goldberg, and Dion (2010) found that twenty-three 
percent of the sample exhibited clinically significant depressive symptoms, with 
methamphetamine mothers (30.7%) more likely than comparison mothers (19%) to 
exhibit clinical depressive symptoms (Liles et al., 2012). In summary, the study by 
Liles et al. (2012) confirmed the presence of increased depressive symptoms and 
parenting stress among mothers who used methamphetamine during pregnancy than 
mothers who did not use methamphetamine during pregnancy.  
 To further support the findings of the study by Liles et al. (2012), Shah et al. 
(2011), found that methamphetamine using mothers were also more like to have a 
psychiatric disorder or illness. Twomey et al. (2013) also determined that maternal 
methamphetamine use was associated to maternal childhood trauma psychiatric 
disorders, though specific conditions were not outlined. Nevertheless, Twomey et al. 
(2013), Liles et al. (2012), and Shah et al. (2011) confirmed that mothers who use 
methamphetamine during pregnancy have an increased chance of developing certain 
psychiatric symptoms.  
In addition to the relationship that exists between methamphetamine use and 
an increased risk of developing psychological deficits, there is also a confirmed 
relationship between methamphetamine use and increased substance abuse. Current 
research shows that many mothers who use methamphetamine during pregnancy are 
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more at risk of having more substance-using family and friends, using other illicit 
drugs, as well as tobacco and alcohol, and developing substance use disorders. In a 
study by Nguyen et al. (2010), 3705 mother/infant pairs consented for participation. 
Among the consented, 204 were exposed to methamphetamine and 3501 were 
unexposed to methamphetamine. Mothers in the methamphetamine group used more 
tobacco, alcohol, and marijuana during pregnancy than the unexposed mothers 
(Nguyen et al., 2010).  
Similarly, the methamphetamine-exposed group in a study by Wouldes et al. 
(2015) had a higher percentage of mothers reporting the use of tobacco and marijuana 
than comparison mothers and a higher daily use of alcohol, cigarettes and marijuana 
across pregnancy. Smith et al. (2008) also determined that more mothers in the 
methamphetamine-exposed group used tobacco, alcohol, and marijuana during 
pregnancy than in the comparison group and were more likely to be heavy users of 
these substances than mothers in the comparison group.  
In their IDEAL study, which included a total sample population of 49 
methamphetamine using mothers and 81 non-methamphetamine using mothers, 
Derauf et al. (2007) found that significantly more women in the methamphetamine 
using group used tobacco (n=35 [71%] versus n=20 [25%]), alcohol (n=24 [49%] 
versus 13 [16%]), and marijuana (n=22 [43%] versus 6 [8%]). Furthermore, 90% of 
the methamphetamine using group reported using methamphetamine in conjunction 
with 1 to 5 other licit and illicit drugs. According to the same study, 74% of the 
methamphetamine using women were determined to have a high probability of 
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developing a substance dependence disorder, compared to 11% of the non-
methamphetamine using women.  
 Building upon previous studies, LaGasse et al. (2012), who conducted an 
Infant Development, Environment, and Lifestyle (IDEAL) study, a longitudinal 
study, reported results that not only further supports those produced in their prior 
works but also those illustrated by others. Relative to the comparison group, LaGasse 
et al (2012) found that the methamphetamine-exposed group was more likely to use 
alcohol, tobacco, and marijuana during pregnancy. According to Brunk (2004), 
methamphetamine using mothers consumed more alcohol (43% vs. 17%), tobacco 
(79% vs. 26%), and marijuana (39% vs. 8%) during pregnancy. These results verify 
those previously mentioned, and thus, lend further validity to the argument that 
methamphetamine use is associated with additional substance abuse.  
In addition to the already mentioned demographic characteristics and their 
correlations to methamphetamine use, Brecht and Herbeck (2014) also concluded that 
methamphetamine using women are also more inclined to display increased sexual 
behaviors, and thus, have more pregnancies. In their study, 153 women who reported 
methamphetamine use during pregnancy were enrolled. While 1996 national statistics 
showed an overall lifetime pregnancy rate of 3.2 per woman, the methamphetamine 
sample showed a significantly higher overall average of 4.6. The methamphetamine 
sample also had a higher than usual average number of pregnancies that ended 
without a live birth: 2.1 per woman versus a national lifetime average of 1.2. The 
methamphetamine group displayed higher levels of sexual risky behaviors than the 
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comparison group at the time they were interviewed. In conclusion, Brecht and 
Herbeck (2014) provide data that provides a strong and effective argument that 
maternal methamphetamine users engage in more sexual behaviors. As a result of 
these behaviors, they are more likely to experience a greater number of pregnancies.  
Based on the current available research, it is evident that demographic 
characteristics among mothers who use methamphetamine drastically differ from 
those who do not. Mothers who use methamphetamine during their pregnancies show 
remarkable differences from mothers in the control group. These differences 
unfortunately work against methamphetamine using mothers and their inevitably 
exposed children and lead to increasingly more severe complications.  
Maternal Complications of Methamphetamine Use 
 Substance abuse by pregnant women continues to be a significant public 
health problem (Gorman, Orme, Nguyen, Kent 3rd, & Caughey, 2014). Perinatal 
methamphetamine use is a concern because it can lead to a variety of maternal 
complications. These complications have the potential to subsequently affect a fetus 
and neonate. 
 Gorman and colleagues (2014) sought to examine the effects of 
methamphetamine use on maternal and neonatal outcomes. Within their study, 8542 
pregnancies (0.4%) that were linked to a diagnosis of methamphetamine use were 
identified and compared with 2,031,328 control pregnancies. Based on the results of 
the study, Gorman, Orme, Nguyen, Kent 3rd, and Caughey (2014) concluded that 
there was a statistically significant increase in hypertensive diseases of pregnancy 
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associated with methamphetamine use. Compared with control pregnancies, 
methamphetamine users had a greater frequency of pregnancy-associated 
hypertension (11.6% vs. 5.8%), gestational hypertension (5.6% vs. 3.2%), 
preeclampsia (6.8% vs. 2.9%), severe preeclampsia (2.5% vs. 0.8%), and eclampsia 
(0.3% vs. 0.1%) (Gorman, Orme, Nguyen, Kent 3rd, & Caughey, 2014).  
 To further support the conclusion made by Gorman and his colleagues 
regarding maternal complications of methamphetamine abuse, additional current 
studies report that methamphetamine use during pregnancy can significantly impact 
the mother by leading to conditions such as pregnancy-related hypertension, 
preeclampsia, severe preeclampsia, and eclampsia. According to Stewart and Meeker 
(1997), increased maternal blood pressure can result in premature separation of the 
placenta from the uterine wall, also referred to as abruptio placenta. The danger 
associated with this complication is that this usually results in spontaneous abortion 
or premature delivery of the fetus (Stewart and Meeker, 1997).  
 Similar to Stewart and Meeker (1997), a study by Good et al. (2010) revealed 
that methamphetamine-abusing mothers showed the common characteristic of 
uncontrolled high blood pressure during their pregnancies, therefore supporting the 
findings by Gorman and his colleagues. Almost 20% of pregnant methamphetamine 
users had uncontrolled blood pressure, and another 10% had experienced placental 
abruption—two exceptionally rare but potential complications during pregnancy that 
affect less than 1% of the general population.   
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 In a study by Scott, Fleming, Bennett, and Graves (2005), a retrospective chart 
review of all pregnancies associated with substance abuse from 1998 until present at a 
tertiary care center was undertaken. Thirty-two records were identified as 
presumptive positive for methamphetamine and/or metabolites. Maternal 
complications comprised 68.75% (23/32) of the total. Preterm labor affected 21.9% 
(7/32). Hypertensive complications affected 25% (8/32) of patients: 15.6% (5/32) 
experienced preeclampsia, 6.25% (2/32) experienced post-partum preeclampsia 
6.25% (2/32), and 3.1% (1/32) experienced a hypertensive emergency. Antepartum 
hemorrhage complicated 12.5% (4/32). Two maternal deaths occurred in their cohort 
(Scott, Fleming, Bennett, & Graves, 2005).  
 From the aforementioned studies, it can be determined that methamphetamine 
greatly affects the general user and produces significant effects on the woman during 
pregnancy. Equally significant and maybe even more importantly, maternal 
methamphetamine use also impacts the process of fetal development throughout 
pregnancy. The manner in which maternal methamphetamine use interferes with the 
normal fetal development process can also lead to negative implications that hinder 
normal neonatal development.  
Effects of Methamphetamine on Placental Transport During Pregnancy 
 Case reports and retrospective analyses have suggested that maternal 
methamphetamine use may be associated with a possible increase in defects of the 
fetal central nervous system, cardiovascular system, gastrointestinal system, oral cleft 
and limb defects. However, while case–control and prospective studies have not 
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confirmed these results, the current findings are consistent for illustrating the high 
likelihood that perinatal or neonatal death can occur as a result of the serious defects. 
This is particularly significant due to the fact that these problems arise as a result of 
maternal methamphetamine use. Therefore, the extent to which women engage in 
methamphetamine use during pregnancy determines the severity of the complications 
that reflect fetal and neonatal outcomes as a result of the drug’s teratogenic effects.  
 A potential risk of illicit drug use is teratogenicity. In exploring the effects of 
maternal use of methamphetamine on the fetus and neonate in more detail, there is 
increasing evidence in recent years that drugs of abuse such as cocaine, 
amphetamines, cannabinoids, and nicotine can interfere with the transport function of 
the placenta, and thus, lead to complications in the fetus, and later, the neonate 
(Gorman, Orme, Nguyen, Kent 3rd, & Caughey, 2014).  
 Methamphetamine transfers from maternal blood to fetal blood via the 
placenta because of its low molecular weight and lipid solubility. It appears that the 
blood concentration of methamphetamine in a fetus is maintained longer than in the 
mother due to the immaturity of fetal metabolic abilities (Sakai, Iwadate, Maebashi, 
Matusumoto, & Takasu, 2015). Under this condition, infants are likely more 
vulnerable to methamphetamine intoxication than adults. Because methamphetamine 
can cross the placenta, many of the clinical effects of maternal methamphetamine use 
are not only also experienced by the fetus, including fetal tachycardia and 
hypertension, but they are more likely to lead to more serious complications (Shah et 
al., 2011).  
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  The placenta is the means of metabolic and nutrient exchange between the 
embryonic and maternal circulations (Ganapathy, Prasad, Ganapathy, & Leibach, 
1998). The function of the placenta as a transport organ is obligatory for fetal 
development because this process, mediated by a variety of transport systems, is 
responsible for the delivery of nutrients from the mother to the fetus. Some of the 
transport systems in the placenta also play a role in the clearance of vasoactive 
compounds, thus maintaining optimal blood flow to this organ (Ganapathy, Prasad, 
Ganapathy, & Leibach, 1998). There is strong supporting evidence to indicate that 
several of these placental transport systems are either direct or indirect targets for 
certain drugs of abuse, including cocaine, amphetamines, nicotine, and cannabinoids. 
These drugs of abuse compromise normal placental transport function and cause the 
systemic release of catecholamines, which therefore leads to vasoconstriction and a 
restriction of nutrients and oxygen to the fetus. In combination, these alterations 
consequently produce detrimental effects on the developing fetus (Ganapathy, Prasad, 
Ganapathy, & Leibach, 1998).  
 Simultaneous with the clinical effects of maternal methamphetamine on the 
mother, there are also a variety of effects that can occur in the fetus, all of which 
result due to a decreased blood supply and ultimately a decreased amount of available 
oxygen to the placenta and fetus. The impaired blood/oxygen supply can retard fetal 
development and, as a result, can potentially lead to additional long-term 
implications. These changes can be reflected as both deviations in physical 
appearance as well as impairments in normal physiological processes.  
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 In their study, Sakai, Iwadate, Maebashi, Matusumoto, and Takasu (2015) 
examined the case of an infant whose source of death was acute intoxication by 
methamphetamine caused by maternal abuse during pregnancy and delivery. The 
umbilical cord was pearly white, dry with 3 vessels and did not present with any 
knots or excessive torsion. The parenchyma of the placenta was red, beefy, and 
spongy without any abnormality including infarction or hematoma. However, upon 
internal examination, a number of ecchymoses were found under the scalp, and a few 
petechiae were visible in the visceral pleura and renal pelvis—all findings that are 
typically not expected. The lungs were dark red and poorly aerated, indicating 
impaired gas exchange. The alveoli were uniformly collapsed and a significant 
amount of squamous epithelia and a small amount of mucus were found within the 
alveoli. Accumulation of substances within the alveoli can result in inadequate 
oxygen and carbon dioxide exchange.  
 Furthermore, the findings obtained from aspirated amniotic fluid were 
consistent with the fetal hypoxemia that was likely caused by the vasoconstrictive 
effects of methamphetamine (Sakai, Iwadate, Maebashi, Matusumoto, & Takasu 
(2015). Overall, the results of the study by Sakai et al. (2015) are significant for 
illustrating the significant effects of methamphetamine use on respiratory function in 
the neonate which can result from a profound impact of methamphetamine on normal 
placental transport of oxygen during pregnancy that compromises the fetus from the 
beginning stages of development.  
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Fetal Complications from Maternal Methamphetamine Use During Pregnancy 
Mechanisms by which methamphetamine can compromise fetal development 
include fetal acidosis, hypoxemia, decreased uterine blood flow, changes in fetal 
blood gases, and an increase in fetal glucose levels (Stewart and Meeker, 1997). 
These alternations ultimately interfere with normal physiological processes that can 
lead to a variety of effects that range in severity, with death as the most serious 
outcome.   
As the fetus develops throughout pregnancy, the nervous system is vulnerable 
to damage at any time because the brain and nervous system are developing 
throughout the pregnancy. While the fetus is susceptible to injury at any point 
throughout the course of pregnancy, the fetus is at greatest risk during the first 
trimester. This is the time when the cells differentiate and develop into limbs and 
organs. Drug use during this time poses a risk to organ development. The second and 
third trimesters involve maturation of the developing body parts. The risk of 
spontaneous abortion in the second trimester and of premature birth in the third are 
increased with drug use. Any one of these effects places the fetus at an increased risk 
of enduring more serious consequences.  
As mentioned earlier, methamphetamine use can result in pregnancy-related 
hypertension in the mother. Increased maternal blood pressure can result in premature 
separation of the placenta from the uterine wall (abruptio placenta). This usually 
results in spontaneous abortion or premature delivery. This is supported by Gorman et 
al. (2014), whose results indicated that methamphetamine users were found to have a 
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higher incidence of abruption and intrauterine fetal death. According to Gorman et al. 
(2014), the odds of abruption were much greater in the methamphetamine using 
population compared with control subjects.  
In addition to Gorman et al. (2014), there is one report in the forensic science 
institution in California, illustrating eight fetal and infant deaths that were associated 
with maternal methamphetamine use (Sakai et al., 2015). The average week of 
gestation at which fetal death occurred was week 30 with a range of 20 to 36 weeks. 
In their case report, titled “Fetal and Infant Deaths Associated with Maternal Abuse”, 
Stewart and Meeker (1997) also examined the six fetal and two infant death cases 
related to maternal methamphetamine abuse. The causes of death, ranging from 
intrauterine death, to asphyxia, to prematurity, to acute bronchopneumonia, and to 
chorioamnionitis, were all associated with maternal methamphetamine use during 
pregnancy. The case report presented by Stewart and Meeker (1997) illustrates the 
significant effects of maternal methamphetamine use during pregnancy on fetal 
morbidity. In summary, Stewart and Meeker (1997) and Sakai et al. (2015) are both 
sources that support the claim made by Gorman et al. (2014) who showed that fetal 
death is increased among methamphetamine users.  
Neonatal Complications from Maternal Methamphetamine Use During 
Pregnancy 
 Neonatal complications are not an uncommon occurrence in children born to 
methamphetamine using mothers. Existing research has demonstrated an association 
between maternal methamphetamine use and an increased risk of physiological 
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complications in the neonate, such as being small for gestational age, low birth 
weight, intrauterine growth restriction, preterm birth, and many more (Gorman et al., 
2014). In their study, Gorman et al. (2014) concluded that gestational age delivery 
was exponentially associated with the use of methamphetamine. Preterm birth, which 
is defined as delivery at <37 weeks 0 days of gestation, and very preterm birth, which 
is defined as delivery at <32 weeks 0 days gestation, were both increased significantly 
increased among maternal methamphetamine users when compared with control 
subjects. According to Gorman and colleagues, neonates had 2.9 times greater odds 
of being born prematurely (<37 weeks of gestation) and 4.5 times greater odds of 
being born very prematurely (<32 weeks of gestation) when compared with neonates 
of non-using mothers. These neonates also had increased odds of incidence of small-
for-gestational-age neonates and birth weight <2500 grams when compared with 
control subjects (Gorman et al., 2014). Gorman et al. (2014) also revealed that other 
studies, which also evaluated the effects of methamphetamine use among pregnant 
women, found a statistically significant decrease in birth weight and head 
circumference among neonates who were born to methamphetamine-abusing mothers 
compared with control subjects.  
 Confirming the results of Gorman et al. (2014), Good et al. (2010) acquired 
results that showed that more than half (52%) of methamphetamine abusing mothers 
had delivered premature births, while only 17% of the control pregnancies were 
preterm. Good et al. (2010) also found that babies born from methamphetamine had 
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lower Apgar scores than those within the control group (6% compared with 1-2%) 
and 12% had intrauterine growth restriction (Good et al., 2010). 
 Similarly, Scott, Fleming, Bennett and Graves (2005) identified thirty-two 
records as presumptive positive for methamphetamine and/or metabolites. Among the 
thirty-two records, there were a total of 27 births, with neonatal complications 
occurring in 70.4% (19/27). Prematurity complicated 51.9% (12/27), admission to the 
Neonatal Intensive Care Unit occurred in 48.1% (13/37) with 84.6% (11/13) 
accounting for preterm neonates. Three of the 32 identified cases resulted in neonatal 
deaths (Scott, Fleming, Bennett, & Graves, 2005). 
 The results of study by Nguyen et al. (2010) demonstrated that infants in the 
methamphetamine-exposed group were born slightly earlier than the unexposed 
group. Eighteen of the methamphetamine exposed newborns (8.8% of the total 
exposed population) were less than 36 weeks’ gestation and 130 were premature in 
the unexposed group (3.7% of the total unexposed population). In summary, maternal 
methamphetamine use leads to an increase in the likelihood of having a child earlier 
in pregnancy by about 50%. Nguyen et al. (2010) also found that the 
methamphetamine-exposed group had an increased likelihood of being born small for 
gestational age.  
 According to Heiss, Goldberg, and Dion (2010), infants exposed to 
methamphetamine tend to be premature, or if born at term, small for gestational age, 
including a small head circumference. Similarly, the results illustrated by Wright, 
Schuetter, Tellei, and Sauvage (2015), who collected data on methamphetamine use 
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and birth outcomes and compared methamphetamine-exposed pregnancies to non-
methamphetamine exposed pregnancies, showed that shorter gestational age and 
decreased birth weight were prevalent among the methamphetamine-exposed infants 
than the non-exposed infants. Similarly, Shah et al. (2010) found that 
methamphetamine-exposed infants were more likely to have smaller head 
circumferences. Shah and his colleagues also found that methamphetamine-exposed 
infants were at an increased risk of being shorter in length, a finding that was also 
demonstrated a study by Diaz et al. (2014), who found that infants exposed to 
methamphetamine were more likely to be shorter and more likely to be born earlier. 
 Oro and Dixon (1987) examined 105 mother–infant pairs with positive results 
of urine toxicology screens at the time of delivery and found that in comparison to 
narcotic-exposed neonates, methamphetamine-exposed neonates were more likely to 
have decreased birth weight and head circumference and to be small for gestational 
age (SGA). These conclusions were also made by another study, in which 66 children 
born to mothers in Sweden who had abused amphetamines during their pregnancy 
were studied. The mean birth weight, height, and head circumference of these 
exposed children were below the means of their unexposed peers (Zabaneh et al., 
2011). 
 Comparably, the methamphetamine-exposed group of children in the study by 
Smith et al. (2010) also had decreased gestational age, length and head circumference 
at birth, though no differences were found in birth weight or incidence of small for 
gestational age or low birth weight by the exposure group, a finding that contrasts that 
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of Heiss et al. (2010) and Shah et al. (2010). In their Infant Development, 
Environment, and Lifestyle Study, LaGasse et al. (2012) found similar results, in that 
methamphetamine exposed infants were on average 5 days younger in gestational age 
and 1.3 centimeters shorter at birth than infants in the comparison group (LaGasse et 
al., 2012).   
 In summary, maternal methamphetamine use leads to a variety of neonatal 
complications that include but are not limited to preterm birth, low birth weight, small 
for gestational age, intrauterine growth restriction, and possibly death. These 
implications are particularly significant because, aside from death, they are often 
predictors of more severe complications. Death is not an uncommon result of the 
complications that occur in fetuses and neonates from maternal methamphetamine 
use. From their study, Good et al. (2010) proved that neonates born to 
methamphetamine using mothers were more likely to experience a greater chance of 
mortality compared to the control group; 4% of methamphetamine-related births died 
shortly after birth whereas only 1% of births from the control group experienced 
neonatal deaths (Good et al., (2010). The complications that neonates must 
consequently face as a result of maternal methamphetamine use may interfere with all 
components of development, and thus, permanently affect the neonate as it progresses 
throughout the later stages of life into adolescence and adulthood. 
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Effects of Perinatal Methamphetamine Use on Complications in Child 
Development  
The general effects of methamphetamine use on the primary user are 
established. The effects of methamphetamine use on a secondarily exposed individual 
are also clearly demarcated. While the general effects of methamphetamine have been 
well studied, knowledge of the effects of perinatal methamphetamine on a child’s 
development is more ambiguous. However, studies already conducted have produced 
results that not only validate the presence of negative implications on both parties of 
individuals, but the consistency of results acquired thus far creates a reliable trend for 
future researchers to follow.  
In creating this project, an extensive review of the literature relating to the 
effects of methamphetamine on maternal, fetal, and neonatal outcomes was 
completed. This project is significant because it may not only lead to additional 
studies that focus on measures to treat methamphetamine use, but it may also lead to 
implications for future research that explore the effects of perinatal methamphetamine 
use on the outcomes of a child following the neonatal period, in its adolescent years, 
and through adulthood. Though more limited than the current available literature that 
outlines the effects of perinatal methamphetamine use on maternal, fetal, and neonatal 
outcomes, previous studies conducted for the purpose of examining the effects on all 
facets of a child’s development following the neonatal period have been equally 
significant. Though future studies may be necessary in order to further validate the 
findings from previous researchers, the results that have been already confirmed are 
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truly significant for illustrating the effects of maternal methamphetamine use a child’s 
cognitive, motor, neurobehavioral, and physical development.  
Effects on Cognitive Development Increasing evidence indicates that 
prenatal exposure to methamphetamine results in severe morphological changes in the 
brain with associated cognitive deficits as the child matures in age (Good et al., 
2010). At present, the only evidence of the long-term effects of prenatal exposure 
comes from a study in Sweden that followed the growth and development of 65 
prenatally exposed children through age 15 years (Wouldes et al., 2014, Diaz et al., 
2014). The results of the study determined that, by age 4 years, exposed children had 
lower IQ scores (103 versus 110) and were more likely to be “problem children” than 
a normative group of Swedish children (Diaz et al., 2014). At age 8 years, prenatal 
exposure was associated with problems among peers in addition to problems with 
aggressive behavior, social adjustment and psychometric assessments. By 14-15 years 
of age, prenatal exposure was associated with decreased school performance, 
particularly in math, language, and physical fitness activities when compared with 
their schoolmates (Lester & Lagasse, 2010). Furthermore, 15% of children were one 
year behind for their age (Wouldes et al., 2014). These findings are also supported by 
those delineated by Diaz et al. (2014). 
In their study, Diaz et al. (2014) enrolled 412 mother–infant pairs (204 
methamphetamine-exposed and 208 unexposed matched comparisons). One hundred 
fifty-one children exposed to methamphetamine and 147 unexposed comparisons of 
the original 208 who attended the 7.5-year visit were included in the study. Based on 
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the results of the study, children exposed to methamphetamine had significantly 
higher cognitive problems subscale scores than comparisons and were 2.8 times more 
likely to have cognitive problems scores that were above average. In summary, 
prenatal methamphetamine exposure was associated with increased cognitive 
problems, which may affect academic achievement and lead to increased negative 
behavioral outcomes (Diaz et al., 2014). Their IDEAL study also found that that 
heavy methamphetamine exposure is associated with subtle deficits in inhibitory 
control—a particularly important component for the development of social 
competence and emotional and cognitive control— at age 5.5 years (Diaz et al., 
2014).  
Similarly, Heiss, Goldberg, and Dion (2010) found similar cognitive 
abnormalities when studying a case report of a 5-year-old girl exposed to 
methamphetamine in utero. At 5 years of age, her overall standardized intelligence 
age score was 72 according to cognitive functioning tests, notably below the norm of 
100. While analysis of speech and language samples were indicated as intelligible and 
speech production was appropriate, her language skills were below-average and 
vocabulary was limited (Heiss et al., 2010).  
 Effects on Motor Development In addition to the effects that maternal 
methamphetamine has on the cognitive development of a child, a study by Wouldes et 
al. (2014) showed that prenatal methamphetamine exposure was also found to be 
associated with poor motor performance at 1 and 2 years. In contrast to the 
aforementioned findings, Wouldes et al. (2014) found maternal methamphetamine 
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use did not affect cognitive development, but rather, resulted in delayed gross motor 
development and lower scores on composite measure of psychomotor performance 
over the first 3 years of life. However, no associations were found between 
methamphetamine exposure and fine motor development. The conclusions made by 
Wouldes et al. (2014) were also validated by Diaz et al. (2014), who reports, from 
their study, that methamphetamine exposed children were more likely to exhibit poor 
suck and poor grasping ability at 1 and 3 years.  
Smith et al. (2010) also found that prenatal methamphetamine exposure 
resulted in early motor disturbances at birth and 1 month. Smith et al. (2010) 
conducted a study in order to examine the effects of prenatal methamphetamine 
exposure on cognitive and motor development in children at 1, 2, and 3 years of age. 
At the completion of their study, they found that there was a subtle methamphetamine 
exposure effect on fine motor performance at 1 year with the poorest performance 
observed in the most heavily exposed children. Furthermore, from their study, Heiss 
et al. (2010) also documented that a 5-year old girl exposed to methamphetamine in 
utero had relatively low scores for gross and fine motor and visual development. At 5 
years of age, her age equivalent score for gross and fine mother and visual 
development was 3 years and 6 months, notably low for what they should be (Heiss et 
al., 2010).  
In conclusion, various studies are positive for confirming that maternal 
methamphetamine use is associated with deficits in motor development in addition to 
cognitive development delays. Further speaking, along with the significant impact on 
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cognitive and motor functioning, there is also evidence, though limited, that illustrates 
that maternal methamphetamine use also influences the neurobehavioral development 
of a child.  
Effects on Neurobehavioral Development While limited research is present 
on the neurobehavioral effects of prenatal methamphetamine exposure in children, 
multiple previously conducted studies show promising results that illustrate profound 
effects. According to an IDEAL study conducted by Smith et al. (2007), 
methamphetamine exposure is associated with multiple maternal psychosocial risks, 
newborn neurobehavioral patterns of decreased arousal, increased lethargy, increased 
total stress/abstinence, physiological stress, and central nervous system stress.  
In a later study, LaGasse et al. (2012) sought to evaluate behavior problems in 
children who were prenatally exposed to methamphetamine at ages 3 and 5 years. A 
total of 330 children (166 exposed and 164 comparison) were assessed for behavior 
problems by using the caregiver report on the Child Behavior Checklist (LaGasse et 
al., 2012). Their IDEAL study found that these children displayed increased 
emotional reactivity and anxious/depressed problems at 3 and 5 years of age, 
externalizing and attention-deficit hyperactivity disorder (ADHD) problems at age 5 
years, and subtle differences in outcomes predictive of ADHD at 5.5 years of age. 
These findings are supported by Heiss et al. (2010), whose case report documented 
that at 5 years of age, a behavioral assessment revealed that methamphetamine 
exposure in utero leads to high scores in oppositional behavior, inattention, 
hyperactivity, social problems, psychomatic issues, and impulsivity, findings that are 
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all consistent with the criteria for ADHD diagnosis (Heiss et al., 2010). Similarly, 
Twomey et al. (2013) also reported clinically significant behavioral problems of 
children with prenatal methamphetamine exposure at 5 years of age. Twomey et al. 
(2013) also found that children with prenatal methamphetamine exposure were more 
than twice as likely to exceed the clinical cutoff for externalizing behavioral problems 
relative to comparison children (Twomey et al., 2013). 
Further expanding on the relationship between maternal methamphetamine 
use and neurobehavioral development problems in children, Zapata et al. (2008), who 
performed a study for the purpose of examining the association between lifetime 
methamphetamine use and recent risky sexual behaviors and lifetime adolescent 
pregnancy, proved that adolescent methamphetamine use affects an individual’s 
behaviors throughout his or her adolescent years. A population-based study of 
heterosexual male methamphetamine users in California reported a strong association 
between methamphetamine use, sex with anonymous and casual female partners, anal 
intercourse, and sex with an injection drug user. In another study of heterosexual 
encounters, methamphetamine use was associated with unprotected anal sex and 
unprotected sex with a new partner (Semple, Strathdee, Zians, & Patterson, 2010). 
Like Semple and colleagues, Zapata et al. (2008) concluded that sexual 
behaviors were common among methamphetamine users. Whereas 31.4% of youth 
who had never used methamphetamine reported having sex during the past 3 months, 
70.4% of ever-users reported recent sexual activity. Furthermore, 7.3% of never-users 
reported having at least 2 sex partners during the past 3 months, compared with 
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34.9% of ever-users, and 3.1% of never-users reported ever becoming pregnant or 
getting someone pregnant, compared with 18.0% of ever-users (Zapata et al., 2008). 
Zapata et al. (2008) also found that methamphetamine use was common among high 
school students, with nearly 1 out of 13 youth reporting lifetime use and that 
methamphetamine use was associated with increased recent sexual activity, having 
>/= 2 sexual partners, and lifetime adolescent pregnancy.  
Supporting the findings by Zapata et al. (2008) is another report by Springer, 
Peters, Shegog, White, and Kelder (2007) who documented a significant association 
between methamphetamine use and lifetime sexual intercourse, and lifetime sexual 
intercourse, initiation of sexual intercourse before age 13, lifetime multiple partners, 
lifetime adolescent pregnancy, and nonuse of condoms during last intercourse. The 
previously mentioned studies have confirmed a strong correlation between maternal 
methamphetamine use in pregnancy and limitations relating to neurobehavioral 
development.  
Effects on Physical Development In addition to delays surrounding cognitive 
development, motor development, and neurobehavioral development, there is also 
evidence, though limited, that delineates an association between maternal 
methamphetamine use and its impact on the physical development of a child.  
Zabeneh et al. (2011) conducted a study to examine the effects of prenatal 
methamphetamine exposure on growth parameters from birth to age 3 years. Aiming 
to assess the effects of prenatal methamphetamine exposure on childhood outcomes 
through examination of weight, head circumference, height and weight-for-length 
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growth trajectory, they enrolled 412 subjects, 204 who were exposed to 
methamphetamine during pregnancy. They found that height trajectory was lower in 
the exposed group versus the comparison children over the first 3 years of life. In 
term subjects, methamphetamine exposure was also associated with a lower height 
trajectory. However, there was no difference in weight, head circumference, or 
weight-for length growth trajectories. These findings of decreased height trajectory 
over the first three years of life are consistent with previous reports of height deficits 
in methamphetamine-exposed children at birth and at 1 and 4 years of age (Eriksson 
et al., 1994). However, as previously stated, there were no differences in head 
circumference, weight, or weight-for-length trajectories, suggesting that although 
exposed children demonstrate continued height growth restriction, the impaired 
growth is not placing them at an increased risk for developmental delay or later onset 
of cardiovascular morbidity (Zabaneh et al., 2011). Based on their study, long-term 
follow-up would be necessary to determine if the decreased height trajectories in 
methamphetamine-exposed children continues into later childhood and affects final 
adult height.  
 In their study, Wouldes et al. (2014), who also examined the growth of infants 
across the first 3 years of age, determined that methamphetamine exposure was 
associated with smaller head circumferences at 1 year, weighing less at 2 years, and 
being shorter at 3 years, when compared with the non-exposed group (Wouldes et al., 
2014). From their studies, Wouldes et al. (2014), Zabaneh et al. (2011), and Eriksson 
et al. (n.d.) confirmed that maternal methamphetamine has an impact on the normal 
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process of physical development in the child. However, due to the fact that there were 
minor discrepancies in their findings, additional studies are indicated in order to 
verify consistency among these specific findings.  
 The previously mentioned findings regarding the relationship between 
methamphetamine use and alterations in child development are promising. This study 
in combination with the previous studies conducted lead to strong implications for 
further research. Future studies will hopefully not only validate the findings 
illustrated by previous researchers, but will also add to the field of knowledge 
surrounding this specific topic.   
Identification of Maternal Methamphetamine Use  
 Given the previously mentioned effects of methamphetamine abuse on the 
maternal user and her child, it is essential that actions are taken to address the current 
issue of methamphetamine use among pregnant women. This can be achieved by 
enhancing measures to adequately assess primary and secondary users. Assessments 
of methamphetamine use may be made, first, through proper identification and 
recognition of several indicators.  
 Methamphetamine abusers tend to have an abundance of energy and may 
participate in repetitive activities. Mothers who are heavy methamphetamine users 
often neglect their personal appearances as well as the appearance and hygiene of 
their children. Additional behaviors that may be observed include anxiety, paranoia, 
mood swings, irritability, hyper-vigilance, confusion, violent threats or actions, and 
possibly psychosis (Hohman, Oliver, & Wright, 2004). Methamphetamine users also 
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have a diminished need to eat or sleep, and have been known to go for as many as 
three weeks without sleeping. Other indicators include pupil dilation, a general smell 
of ammonia, or stale urine (Hohman, Oliver, & Wright, 2004).  
 Skin manifestations may also be quite apparent: users may pick at their skin in 
search of crawling bugs, resulting in abrasions and excoriations that often lead to the 
development of polymicrobial infections (McGuinness and Pollack, 2008). 
Furthermore, chronic use can lead to the formation of skin abscesses, particularly on 
the face, and users can exhibit weight loss, poor hygiene, and dental problems 
(Hohman, Oliver, & Wright, 2004). A more chronic sign of methamphetamine abuse 
is “meth mouth”. However, many illicit substances cause xerostomia, which is the 
basis for poor oral health in substance abusers (Rhodus & Little, 2005). Periodontal 
bone loss can also give methamphetamine users an aged appearance.  
If a mother demonstrates the aforementioned signs and symptoms, the nurse 
can begin by approaching the parent in a nonjudgmental manner. The nurse can 
inquire about the parent’s general health and suggest that skin conditions and poor 
oral health are related to a variety of health problems. The nurse can suggest that drug 
abuse sometimes causes these symptoms and that treatment for addiction works. 
Nurses should become familiar with local treatment options and how to refer patients 
with substance use disorders. If a parent admits to substance abuse, the child or 
children should be assessed for abuse and neglect. Nurses should be knowledgeable 
of and prepared to contact local child welfare authorities if abuse and neglect are 
evident (McGuinness & Pollack, 2008). 
THE EFFECTS OF PERINATAL METHAMPHETAMINE USE 
 
61 
Currently, recommendations regarding identification and treatment of 
methamphetamine users during pregnancy have been made and implemented by the 
American Congress of Obstetricians and Gynecologists (ACOG) Given the potential 
risks to maternal, fetal, and infant health with methamphetamine use in pregnancy, 
identification of use is important and of priority, according to ACOG (2011).  
Successful identification of methamphetamine through the various indicators 
previously mentioned can be obtained through a complete recount of the client’s 
history. Aside from the more obvious signs that confirm methamphetamine use, all 
pregnant women should be asked about past and recent smoking, alcohol, and other 
drug use as part of the prenatal history, ACOG reports (ACOG, 2011). Asking about 
partner substance use may aid patient disclosure of personal drug use. Studies have 
shown that pregnant methamphetamine users are more likely to be white, young, and 
unmarried. Women using methamphetamine often seek prenatal care late in 
pregnancy and experience poor weight gain. Signs of methamphetamine use include 
“track marks from intravenous injection, malnutrition, severe dental decay, and skin 
abscesses from skin picking secondary to formication” (ACOG, 2011).  
In collaboration with the Association of Women’ Health, Obstetric and 
Neonatal Nurses, Amy McKeever (2015) further delineates specific measures relating 
to identification of substance users. According to McKeever, screening tools are 
appropriate for identifying substance abusers (McKeever, 2015). In addition to 
screening tools, health care providers can all also inquire about substance abuse by 
introducing the topic in conversation and asking direct questions. Most effective 
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antepartum care is care that begins in the first trimester of pregnancy and is consistent 
throughout the pregnancy, McKeever reports. Following recognition and 
identification of a substance abuser, collaborative care between health care 
professionals, including nurses, primary care providers, and obstetrical providers, and 
substance abuse treatment providers as well as social services is necessary in order to 
ensure that the patient’s health demands are met (McKeever, 2015). Additional care 
cannot be implemented until adequate identification is carried out.  
Summary 
 In summary, the implications of methamphetamine use are vast and prevalent 
in the U.S. This epidemic is also well recognized in Tennessee and Hamilton County. 
The number of men and women that continue to use methamphetamine speaks to the 
importance of this issue. Among these individuals, pregnant women comprise a 
significant portion of female methamphetamine users across the United States. The 
duration of effects that result from maternal methamphetamine use on a mother as 
well as the fetus and neonate far surpass the period of pregnancy. The overall effects 
of methamphetamine on an individual are alarming enough due to its highly addictive 
nature. However, the potential complications that can arise for not only a mother but 
also her child due to maternal methamphetamine use pose a much more significant 
issue.  
 The detrimental effects that a child can experience as a result of maternal 
methamphetamine use during pregnancy can potentially cause effects that remain 
with the child throughout the remainder of its life. These effects can weigh heavily on 
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the neonate both physiologically and psychologically and can ultimately lead to 
death. While the mother, who is partaking in methamphetamine use, may or may not 
be aware nor concerned about the implications that the drug is having on her 
physiological and psychological well-being, it is important to make her aware of the 
negative complications that methamphetamine use can have on her and her child, 
both in utero and long term. As health care professionals who may encounter these 
individuals in the clinical setting, nurses must be prepared carry out the clinical 
functions expected of nurses. These responsibilities include proper identification and 
health teaching. In order to accomplish this, they must be fully aware of the general 
implications of methamphetamine use, its impact on a mother and child in pregnancy, 
as well as signs and symptoms of methamphetamine use. Knowledge in these areas 
will not enhance their practice as nurses but to allow them to educate their patients 
and enhance the patients’ knowledge so they can make more informed choices as well 
as understand their current ones.    
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Chapter 3 
Methodology 
Purpose of the Study 
 The purpose of this study was to provide educational content on 
methamphetamine, the general effects of methamphetamine use, and the effects of 
methamphetamine use on maternal and child outcomes during and following 
pregnancy. In light of what is currently known about methamphetamine including its 
associated effects and complications, this project took a unique approach to 
enhancing the practice of nurses by educating nursing students so that they are better 
equipped to not only identify and recognize signs and symptoms of 
methamphetamine users in the clinical arena but also to increase awareness and 
knowledge through education.  
 Education as a means of disease prevention and health promotion served as 
the methodological component of this project. The substantial and significant amount 
of knowledge acquired in all areas related to methamphetamine including the 
production of methamphetamine, effects of methamphetamine use, characteristics of 
methamphetamine users, the general complications of methamphetamine use, and the 
complications of maternal methamphetamine use on a mother and her child was 
compiled and integrated into a standardized patient education program as a method of 
teaching among the third level baccalaureate nursing students. 
 Since limited knowledge on this topic is currently made available to the 
students, this project provided them with specific information on the definition of 
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methamphetamine, the general effects of methamphetamine use, and signs and 
symptoms that are indicative of methamphetamine use. Knowledge of this 
information was anticipated to enhance the students’ practices as future nurses by 
improving their abilities to better identify methamphetamine users within the clinical 
care setting as a result of an increase in knowledge. Acquisition of this knowledge 
will, in addition, enable them to relay this information to their patients and educate 
them on the detrimental effects of methamphetamine so that they are more aware, can 
make more informed choices regarding initiation of drug use, and can understand the 
implications of their current choices to use methamphetamine.  
  This information was presented through the use of various teaching strategies, 
participant questions were answered, and activities that reinforced learning were 
incorporated. In addition to the methamphetamine educational program, PRE/POST 
testing was included in order to serve as a measurement of the learning received 
during the educational program by comparing what the individual knew before in a 
PRE survey and after the educational experience in a POST survey. PRE/POST 
testing allows one to quantify the knowledge gained from a group of students with 
diverse learning styles and educational backgrounds. More specifically, the tests 
indicate how the students are learning. In this case, the PRE/POST surveys 
incorporated content that was included in the educational program that was directly 
related to the learning objectives and outcomes. The PRE/POST assessments were 
developed and distributed electronically using Qualtrics software.  
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Participants 
The participants of this study were selected by a method of convenience 
sampling based on those currently enrolled in the NURS 3350 Care of the 
Childbearing Family course at the University of Tennessee at Chattanooga (UTC) 
School of Nursing. During the 3rd semester of nursing school, the academic 
curriculum is focused on nursing care of a mother and her child before, during, and 
following pregnancy. For this reason, targeting the population of students who were 
enrolled in the third level of study and who were undergoing a course regarding 
childbearing families was ideal. The number of students included in this study was 
based on the number of individuals enrolled in the NURS 3350 course. The total 
number of students that were listed as enrolled in the NURS 3350 course was 39, with 
seven of the students being male and 32 students being female. The participants of 
this study were not minors, involuntarily institutionalized, nor mentally handicapped.  
Project Setting 
It was necessary to obtain consent from the study participants in order to 
proceed with the project. The consent was provided by the participants in this study. 
Consent for participation was requested prior to completion of the PRE survey (see 
Appendix A). Participants certified their consent by affirming that they agree with the 
terms of participation. Informed consent was reflected as a written document at the 
beginning of the PRE survey that was distributed on September 6, 2016. The students 
were provided with contact information should they wish to contact the principal 
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investigator or the UTC Institutional Review Board (IRB). Following affirmation of 
consent, the participants proceeded to complete the electronic PRE survey. 
Approval was also obtained by the Institutional Review Board (IRB) at the 
University of Tennessee at Chattanooga because the implementation of the proposed 
educational teaching intervention required participation of human subjects, though no 
new research was conducted. No person was put in a dangerous situation nor harmed 
in any way and patient rights were protected during this study.  
The participants of this project were also assured and reminded that 
participation in this study would affect the outcome of his or her grade within his or 
her academic courses. However, the students were made aware that knowledge of 
information provided in this program would be assessed as part of the course learning 
outcomes; therefore, assessment of knowledge was reflected on course examinations.  
While the educational teaching program was anticipated to benefit the author 
and contributing members of this project, the targeted population of this project were 
the participants and ultimately, those that they may encounter in clinical practice and 
the work arena as nursing students and registered nurses. Increasing awareness and 
knowledge of the prevalence of methamphetamine drug use among BSN nursing 
students was expected to enhance the practice of these students within the clinical 
setting as both student nurses and future registered nurses, and, thus, increase holistic 
and patient-centered care, which is directly related to positive patient outcomes.  
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Inclusion/Exclusion Criteria 
Inclusion criteria for this project consisted of several items. The participants 
of this study were third level baccalaureate nursing students who were enrolled in 
NURS 3350 Care of the Childbearing course at the University of Tennessee at 
Chattanooga. Exclusion criteria included individuals who were not enrolled in the 
NURS 3350 course in the Fall 2016 semester, individuals who were minors, 
involuntarily institutionalized, and mentally handicapped. Although students were 
allowed to withdraw from the study at any point in time, it was anticipated that every 
student would participate throughout the entire course of the study. Exclusion criteria 
also consisted of those who chose to withdraw at any point while the study was in 
effect.   
Risks/Benefits to Participants 
There were no foreseeable risks to the individuals participating in this study. 
There were, on the other hand, many notable benefits anticipated from this study. The 
specific information provided in this study projected to benefit nursing students by 
enhancing their knowledge about methamphetamine. Furthermore, this study was also 
expected to benefit the students themselves by contributing to their field of 
knowledge, thereby enhancing their practices as nurses and benefitting society as a 
whole. It was hypothesized that by the end of the study, the sample population would 
be more knowledgeable about methamphetamine and thus able to use this information 
to further educate their patients on this particular topic as well.  
 
THE EFFECTS OF PERINATAL METHAMPHETAMINE USE 
 
69 
Incentives 
No incentives were offered for participation in the study and students were not 
penalized for choosing not to participate in the PRE/POST surveys. Students 
choosing not to participate in the PRE/POST surveys were still expected to participate 
in the class during which the methamphetamine-related content was presented to the 
students as they would already be present for course lecture. They were also expected 
to participate in the subsequent assignments and examinations at the discretion of the 
course instructor as part of the course structure and outline. However, their 
reflections/observations were omitted from data analysis and/or inclusion in any 
presentation of the results.  
Limitations 
 There were a couple of limitations to this study. One limitation to this study 
pertained to the sample size. The sample population consisted of 39 baccalaureate 
students. A second limitation to this study was that the study was implemented at 
only one southeastern university school of nursing. The combination of these factors 
could potentially affect generalization of the study and results.   
Project Instrument 
 The PRE/POST survey instruments utilized in this study were self-constructed 
with the guidance of faculty within the School of Nursing at UTC. A test blueprint 
was constructed prior and served as a tool to guide the development of the PRE/POST 
surveys. The PRE/POST surveys consisted of 25 content-based questions. The PRE 
survey also contained 5 questions that were used in order to elicit demographic data. 
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The POST survey contained a reflection question that enabled the students to provide 
reflection statements (see Appendix B). 
The content presented in the PRE/POST surveys addressed topics relating to 
the history, origin, and prevalence of methamphetamine, the definition of 
methamphetamine, the overall effects of methamphetamine, the impact of maternal 
methamphetamine use in pregnancy on maternal and child outcomes, and signs and 
symptoms of methamphetamine. The content provided in the PRE/POST surveys and 
educational presentation were reviewed by nursing faculty who are knowledgeable 
and well experienced in the areas of content structure.   
The reliability of the various components of this study, inclusive of the 
PRE/POST assessments, educational content, and method of data analysis, were 
considered in terms of face validity. The instrument was verified for accuracy by 
nursing faculty prepared at the doctoral level and who possess content-structure 
expertise. Thus, face validity for the instrument was established. 
Methods/Procedures 
The research questions for this study were:  
1. Is there a significant difference in the knowledge of third level BSN nursing 
students regarding methamphetamine after the presentation on 
methamphetamine content? 
2. How does the presentation on methamphetamine impact the anticipated 
future clinical practice of the student? 
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These research questions were measured by the data acquired from the PRE/POST 
assessments and were expected to be fully addressed by the completion of the study.  
 In developing the educational program and PRE/POST assessments, there 
were a series of learning objectives and outcomes that the students were anticipated to 
address. By the end of the presentation, it was expected that the participants would be 
able to:  
1. Define what methamphetamine is. 
2. Describe the effects of methamphetamine use. 
3. Recognize signs and characteristics that are indicative of methamphetamine 
use during pregnancy. 
4. Discuss how to identify methamphetamine use. 
5. Explain the maternal, fetal, and neonatal complications that can occur as a 
result of maternal methamphetamine use during pregnancy. 
At the conclusion of this study, it was anticipated that the students would meet the 
previously listed learning objectives and in conjunction, the preceding research 
questions would be answered. 
This study incorporated components that were significant to both quantitative 
and qualitative methods of research as well a cross sectional model. A quantitative 
approach was applicable to this study due in large part to the fact that enhancement of 
learning was assessed using PRE/POST surveys. This study also incorporated 
qualitative characteristics, for student perceptions regarding integration of 
information learned into future practice was evaluated through a reflection 
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component. The PRE/POST surveys not only focused on measurement of knowledge 
gain, but also on feelings, ideas, and insights. A cross-sectional model was chosen for 
the reason that the study took place in a short period of time and the participants 
would not be followed long-term. They would only be followed for the duration of 
time from the implementation of the PRE survey to the implementation of the POST 
survey.   
Before the educational content was presented, a PRE survey was distributed to 
the participants of the study on the agreed “entry point” of the study. In this case, the 
study commenced in the first week of September when the students completed the 
PRE survey. The PRE survey, a formative evaluation, was intended to serve several 
purposes: knowledge of the current status of a group would guidance for future 
activities as well as the basis of comparison for a POST survey results; administering 
a test of entry knowledge helped to determine whether assumed prerequisites were 
achieved. The process of creating the PRE/POST surveys involved constructing 25 
questions that effectively tested the participant’s knowledge prior to the 
implementation of the educational program and after the concepts of the educational 
program were presented. The PRE survey also contained 5 questions that inquired 
about the student’s current knowledge, attitudes, and personal experience regarding 
methamphetamine. This content was based on the learning outcomes and objectives 
that were established for the program. Completion of the PRE survey was expected to 
take no more than 45-60 minutes and was distributed electronically via Qualtrics 
software. The PRE survey was distributed and completed on September 6, 2016.  
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 The methamphetamine education program was presented during the time the 
antepartum content was being introduced.  The educational program consisted of a 
standard patient role play scenario as well as a presentation via Prezi software. The 
educational content was provided on October 4, 2016. This was the optimal time to 
present the methamphetamine content. The length of the methamphetamine education 
program was limited to no more than 1 hour. The educational program was intended 
to provide 30-45 minutes for the presentation and 15 minutes for questions.  
 Immediately following the presentation of educational content, a POST survey 
was distributed to the participants. The POST survey, in addition to the PRE survey, 
was a valuable methodology to measure the learning acquired as a result of the 
educational program, to analyze the appropriateness of learning objectives and 
outcomes, to recognize individuals who needed additional help, and to target any 
instructional needs to improve the program. The POST survey measured application 
and impact of learning. Mirroring the PRE survey, the POST survey consisted of 25 
questions that pertained to the learning objectives as well as the content of the 
educational program. Completion of the POST survey was done electronically via 
Qualtrics software and took no more than 45-60 minutes.   
 Following completion of the PRE/POST surveys, the tests were collected and 
the item-by-item answer data was analyzed using SPSS Statistics software. This 
software allowed for management of data acquired from the PRE/POST assessments 
and calculation of the statistics. The information compiled from this software 
provided a clear picture of whether there was significant POST survey data.  
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 In addition to the 25-item PRE/POST assessments, which provided a 
quantitative approach of methodology, a reflection component was included which 
provided a qualitative approach. In contrast to the PRE/POST assessments, which 
included questions using factual content and provide answer options that have already 
been generated, the reflection component encouraged the participant to provide his or 
her own self-assessment to a question regarding the impact of the teaching 
presentation on future clinical practice. The purpose of the reflection component was 
to acquire insight and perspective on the participant’s thoughts, feelings, opinions, 
and insight regarding the topic content. This was an effective method to determining 
how the information presented was anticipated to impact and be applied to the 
student’s clinical setting and work arena in the future. 
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Chapter 4 
Results 
The purpose of this project was to provide specific information regarding the 
effects of perinatal methamphetamine use on maternal and child outcomes to 
baccalaureate nursing students studying childbearing families in the third level of 
study at the University of Tennessee at Chattanooga. By educating nursing students 
through defining methamphetamine, describing the general effects of 
methamphetamine use, and outlining the effects of perinatal methamphetamine use on 
a mother and child, it was predicted that the study participants would be more 
prepared, as nursing students and future registered nurses, to recognize signs and 
symptoms indicative of methamphetamine use, especially in pregnancy, and 
subsequently increase awareness on the detrimental nature of this drug.  
The research questions that guided this study were: 
1. Is there a significant difference in the knowledge of third level BSN nursing 
students regarding methamphetamine after the presentation on 
methamphetamine content? 
2. How does the presentation on methamphetamine impact the anticipated 
future clinical practice of the student? 
At the conclusion of the study, the quantitative results of the PRE/POST 
surveys were compiled and compared. The following table (Table 1) contains the 
individual questions used in the PRE/POST survey instrument to assess the student’s 
level of knowledge regarding methamphetamine as well as the correct response to the 
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question. Table 1 also lists the percentage of students who answered correctly on the 
PRE and POST surveys. A paired samples t-test was conducted to determine 
differences in PRE/POST knowledge scores. The result indicated a significant 
increase in student knowledge from PRE to POST test (t (33) = -16.94, p < .001, d = 
3.66). The Cohen’s d (3.66) represents a large effect size indicating significant 
practical impact in the change from PRE to POST knowledge scores. These results 
reflect the quantitative data component of the study. While 24 of the 25 questions 
illustrated an increase in knowledge from PRE to POST survey, it should be noted 
that one question (Question 23) illustrated a decrease in knowledge from PRE to 
POST.  
Table 1.  
PRE/POST Knowledge Survey Questions and Correct Answers with Student Response 
Percentages 
 
PRE/POST Survey Question and Correct Response PRE 
(%) 
(n=36) 
POST 
(%) 
(n=36) 
1. Which of the following most accurately describes the 
prevalence and severity of methamphetamine use as it relates 
specifically to the state of Tennessee? 
Answer: Top 3 
 
41.7 83.3 
2. Methamphetamine is also known by various street names, 
including all of the following except? 
Answer: Zoom 
 
30.6 97.2 
3.What is the most common ingredient in methamphetamine? 
Answer: Pseudoephedrine 
 
30.6 97.2 
4. Additional ingredients that are essential to the process of 
manufacturing methamphetamine include which of the 
following? 
Answer: Lithium 
41.6 80.6 
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5. Under what category of drugs is methamphetamine classified 
as? 
Answer: Stimulant 
 
61.1 100.0 
6. The physiological and psychoactive effects of 
methamphetamine occur due to mechanisms that increase levels 
of all the following neurotransmitters except: 
Answer: Epinephrine 
 
0.00 52.8 
7. This neurotransmitter is involved in reward, motivation, 
pleasure, and motor function. Increased levels of this 
neurotransmitter result in the sense of increased alertness and 
intense euphoria, effects that lead people to use 
methamphetamine. 
Answer: Dopamine 
 
52.8 91.7 
8. The effects of methamphetamine use occur as a result of the 
drug’s effect on which primary body system? 
Answer: Nervous System 
 
80.6 94.4 
9. Pharmaceutical methamphetamine is still available legally and 
is prescribed, though infrequently, to treat all of the following 
except: 
Answer: Constipation 
 
72.2 94.4 
10. Methamphetamine causes which of the following acute short-
term effects? 
Answer: Increased sexual pleasure 
 
22.2 83.3 
11. Additional acute short-term effects of methamphetamine use 
include which of the following? 
Answer: Irregular heartbeat 
 
83.3 83.3 
12. Methamphetamine causes which of the following chronic 
long-term effects? 
Answer: Hallucinations 
 
38.9 83.3 
13. Effects due to secondary methamphetamine exposure include 
which of the following? 
Answer: Respiratory distress 
 
25.0 75.0 
14. Methamphetamine often leads to consumption of increased 
doses in order to produce the same desired effects. This lends to 
the drug’s highly dangerous nature and is referred to as? 
86.1 91.7 
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Answer: Tolerance 
 
15. In regards to the demographic characteristics that are unique 
to the population of methamphetamine users, current literature 
studies illustrate that methamphetamine using women are more 
likely to demonstrate which of the following? 
Answer: Low socioeconomic status 
 
88.9 100.0 
16. Common maternal complications that can occur as a results of 
maternal methamphetamine use in pregnancy include all of the 
following except: 
Answer: Miscarriage 
 
2.8 58.3 
17. Studies show that methamphetamine-abusing mothers are at 
risk of having seizures, which occur as a result of what? 
Answer: High blood pressure 
 
30.6 69.4 
18. Maternal methamphetamine use can lead to alterations in 
placental function which ultimately compromises fetal 
development by: 
Answer: Decreasing available oxygen to the fetus 
 
72.2 88.9 
19. The fetal hypoxemia secondary to maternal methamphetamine 
use is likely caused by: 
Answer: Vasoconstriction 
 
47.2 100.0 
20. Common fetal complications that can occur as a result of 
maternal methamphetamine use include which of the following? 
Answer: Pre-term birth 
 
83.3 97.2 
21. Neonates born to methamphetamine abusing mothers have 
been shown to display which of the following? 
Answer: Decreased head circumference 
 
22.9 72.2 
22. Additional neonatal complications of maternal 
methamphetamine use include which of the following? 
Answer: Small for gestational age 
 
94.4 97.2 
23. Behaviors that may be observed in mothers who are using 
methamphetamine include which of the following? 
Answer: Paranoia 
 
83.8 77.8 
24. What common physical manifestation is often an indicator of 
methamphetamine use? 
50.0 97.2 
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Answer: Dental caries 
 
25. Methamphetamine users often the sensation that there are 
insects creeping on top of, or underneath, the skin. This causes the 
user to pick at or scratch the skin, which can create open sores. 
This common hallucination is referred to as: 
Answer: Crank Bug 
19.4 97.2 
TOTAL AVERAGE NUMBER OF QUESTIONS ANSWERED 
CORRECTLY 
 12.5 
(50%) 
21.7 
(87%) 
 
The quantitative data demonstrated statistically significant results, and 
adequately addressed the research question: Is there a significance difference in the 
knowledge of third level BSN nursing students of methamphetamine after 
presentation of methamphetamine content? The results acquired from the PRE 
surveys illustrated an apparent knowledge deficit among the third level nursing 
students enrolled in the maternal-childbearing course regarding the effects of 
perinatal methamphetamine on maternal and child outcomes. Of the total 25 questions 
listed in the PRE/POST surveys, the average number of questions answered correctly 
in the PRE survey was 12.5 (50%). In contrast, the average number of questions 
answered correctly in the POST survey was 21.7 (87%). The educational presentation 
significantly influenced the student’s repertoire of knowledge surrounding perinatal 
methamphetamine use by resulting in an approximated 75% increase in knowledge 
gain, as evidenced by the significant differences in the average number of questions 
answered correctly in the PRE survey versus the POST survey. Utilization of 
PRE/POST surveys to assess content knowledge prior to and following the 
educational presentation was an effective means for acquiring quantitative data and, 
thus, answering the first research question. Comparison of the quantitative results in 
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the PRE survey and POST survey showed a significant increase in the knowledge of 
the study participants after the presentation of methamphetamine-specific 
information. 
Qualitative results were also obtained from the study. Qualitative data was 
reflected in statements made by each study participant in response to a question 
regarding applicability of the information presented in this study in future nursing 
practice. The students were asked to provide a response to the following question: 
How do you anticipate using this information in your future practice as a nurse? Of 
the 36 students who completed the PRE/POST surveys, the qualitative question was 
answered by 33 participants. Table 2 provides a summary of the themes that were 
reflected in the free response statements by the participants. Table 2 also identifies the 
prevalence of each theme and the percentage of students whose responses supported 
each theme. Four major themes emerged from the qualitative data in the POST 
survey. The four major themes are: (1) educating others, (2) identification of drug 
use, (3) patient care, and (4) overall presentation benefit.  
Table 2. 
Major Themes That Emerged from Open Response Questions 
Theme POST% 
(n=33) 
Educating others 
 
63.64 
Identification of drug use 
 
51.52 
Patient care 21.21 
  
 Overall presentation benefit 96.97 
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Based on the qualitative data, 64% of the students who responded expressed, 
through their statements, that the information provided in this study had a significant 
impact on their abilities to educate others. The responses suggested that information 
from this presentation could be communicated to others in order to increase 
knowledge and awareness. Communication of this information could be integrated in 
teaching. The written responses provided by these students confirmed that knowledge 
of this information will allow them to “educate women and others that are using 
meth” and “educate the patient on the maternal and fetal complications that can occur 
due to the substance”. Of the students who expressed how this presentation is 
anticipated to positively influence in their abilities to educate methamphetamine 
users, many also stated that this presentation will also increase their abilities to 
educate the general public and other health care professionals. Thus, the responses 
provided by the students suggested that an educational presentation could improve 
one’s ability to enhance knowledge and awareness among others by providing 
teaching. 
A second major theme illustrated in the qualitative data concerns the effect of 
educational presentation on the students’ ability to identify methamphetamine 
through accurate recognition of specific signs and symptoms. Reflective statements 
made by the students suggest that that the teaching information improved the 
students’ abilities to “know signs and symptoms of using”, thus enhancing their 
abilities to “identify potential meth users”, ultimately making methamphetamine users 
“easier to spot”. Over one half (51.52%) of the respondents provided a response that 
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supports this idea. Based on the students’ responses, educational teaching can have a 
significant impact on one’s ability to identify methamphetamine users by enabling 
them to distinguish specific signs and symptoms indicative of methamphetamine 
abuse. 
A third major theme was noted in the reflective statements by the students. 
Approximately 20% of the respondents reported that the teaching provided in this 
study was beneficial to increasing their confidence and ability to care for 
methamphetamine users. The qualitative data confirmed the students’ beliefs that 
increased knowledge on this topic will allow them to “care for those using 
methamphetamine use” through an improvement in their abilities to “assess my 
patients”, “complete more pointed and effective assessments”, and to identify “what 
resources we can give them rather than just let the case worker handle it”. In 
summary, written statements by 21.21% of students suggest that educational teaching 
can enhance level of confidence and the ability to care for primary and secondary 
methamphetamine users through assessment and referral. 
 A fourth major theme was evident in the written responses made by 32 of the 
33 study participants. Written statements by all but one student (96.97%) suggest that 
the educational presentation was beneficial overall and will positively enhance future 
nursing practice. One student (3.03%) reported uncertainty regarding utilization of the 
teaching information in professional practice due to reservations surrounding what 
particular field of nursing the student intends to pursue. Another student expressed 
acknowledgement of feelings of sadness and anger regarding primary and secondary 
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methamphetamine use. Based on the qualitative results, it appears that the educational 
presentation also elicited personal judgment and feelings of frustration and anger. In 
response to the question regarding utilization of this information in nursing practice, 
one student stated that “this information” and “methamphetamine in pregnancy 
angers me, and it makes me want to take action”, and that “she [mother] should be 
prosecuted”. Despite this, an overwhelming number of the responses (96.97%) 
provided by the students show that the educational teaching was beneficial and will 
positively impact each student’s future practice as a nurse, whether through patient 
teaching, identification of drug use, patient care, or overall general practice.  
The qualitative data acquired from the free response statements made by the 
students in the POST survey demonstrated meaningful student impact, and adequately 
addressed the second research question of this study: How does the presentation on 
methamphetamine impact the anticipated future clinical practice of the student? Four 
major themes were noted throughout the students’ responses – (1) educating others, 
(2) identification of drug use, (3) patient care, and (4) overall presentation benefit. 
Based on their own words and the subsequent themes that were drawn from their 
responses, it is apparent that the educational presentation on methamphetamine will 
have a positive impact on the students’ future clinical practice as nurses. Aside from 
the response made by one student, who reported uncertainty surrounding use of this 
information in practice, feedback from a greater majority of the students (96.97%) 
showed that the students felt the study was both relevant and applicable to their 
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general knowledge base as well to their practice as both student nurses and future 
registered nurses.  
Presentation of methamphetamine content resulted in increased knowledge of 
the effects of methamphetamine and the outcomes of perinatal methamphetamine use 
on maternal and child well-being, as evidenced by the quantitative data. The students 
report that increased knowledge stimulated consideration of personal attitudes and 
beliefs. They anticipate that it will influence their abilities to further educate the 
general public, their work colleagues, and patients, to identify signs and symptoms of 
primary and secondary methamphetamine use. They report that identification of use 
will enable them to assess and initiate referrals for their patients. Their ability to carry 
out these functions, as stated in their written responses, reflects the overall significant 
impact this information will have on their future clinical practice. As a result, the 
qualitative data effectively addressed the research question.   
An overall look at the quantitative and qualitative data illustrated that the 
educational presentation led to a significant increase in knowledge of content and 
anticipated use of information from the educational presentation in future practice can 
lead to potential positive implications. While examining the PRE/POST data, it was 
apparent that some of the data reflected only minor knowledge gains. Comparison of 
the data also revealed that there were specific questions in which only minor 
increases in the percentage of students answering a question correctly were observed. 
There were many questions in which students demonstrated a high level of 
knowledge on the PRE survey. This is reflected in the PRE/POST percentage scores 
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for Questions 8, 9, 11, 14, 18, 20, and 22. In light of this finding, the PRE/POST 
survey data showed an overall statistically significant increase in the average number 
of questions that were answered correctly from the PRE survey to the POST survey. 
However, while the data was statistically significant, there is still room for 
improvement.  
 Interpretation of the data leads to future implications that involve considering 
what improvements can be made and developing solutions to remedy these issues in 
future studies. In this case, additional studies that address the minor increases in 
knowledge gain from the PRE to POST survey would be necessary. As shown by the 
data, another important point to note is that fewer respondents answered Question 23 
correctly in the POST survey when compared with the percentage noted in the PRE 
survey data. In order to address these specific areas, it is possible to consider the 
content structure outlined in the presentation. Analysis of the PRE/POST survey 
questions, survey answer choices, and student interpretation of the PRE/POST survey 
questions and teaching is also necessary to allow the questions to be clarified in order 
to reduce ambiguity and increase reliability. Improvements within these areas may 
potentially lead to an even more significant difference in knowledge gain in future 
studies.   
Based on the quantitative results, additional information would be necessary if 
these students intend to focus their practice in this area or plan to practice within a 
setting in which this population of patients is more prevalent. Regarding the 
qualitative data, the written responses from the students, the major themes that 
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surfaced from these comments, and the percentage of respondents whose responses 
supported these themes indicate that there was strong impact on how they anticipate 
using this information in their future practice.   
 In summary, the quantitative data showed that there was a significant 
difference in the knowledge of BSN students after presentation of methamphetamine 
content. Comparison of the PRE/POST data showed that the presentation of 
methamphetamine content led to an approximate 75% increase in knowledge gain. 
The qualitative data showed that the presentation of methamphetamine content is 
anticipated to impact the students’ future clinical practice. Increased knowledge and 
awareness of methamphetamine is expected to influence future practice by enabling 
the third level nursing students to integrate this knowledge through health teaching, 
identification of drug use, patient care, and in general nursing practice. 
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Chapter 5 
Conclusion 
The first research question addressed in this project was: “Is there a 
significance difference in the knowledge of third level BSN nursing students of 
methamphetamine after presentation of methamphetamine content?”. From the 
quantitative data results, there were statistically significant increases in the 
knowledge of methamphetamine use and related maternal and child complications. 
The second research question of this project was: “How does the presentation on 
methamphetamine impact the anticipated future clinical practice of the student?”. 
From the qualitative data results, the students report that they anticipate that the 
information they have learned will have a strong positive impact on their future 
practices. Based on the quantitative and qualitative data results, the research questions 
were addressed and the learning outcomes were met.  
Utilization of a combined teaching method, which included a standardized 
patient role play scenario and a Prezi presentation, was an attempt to provide specific 
information in an innovative and informative manner. The results acquired from the 
PRE/POST data showed that the teachings strategies used supported a sizeable 
knowledge gain, as evidenced by the quantitative data results. The students reported a 
strong anticipated impact of the knowledge on their future practice, as reflected in the 
qualitative data. Overall, results of this project were that the students acquired 
knowledge about methamphetamine and anticipated a strong impact on their 
professional nursing practices. The results of this project create a solid foundation for 
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additional studies on teaching the effects of perinatal methamphetamine use and 
related maternal and child complications. 
Implications for Future Research 
Nurses possess unique responsibilities as they serve as both health care 
providers and educators. The more knowledgeable nurses are, the more equipped they 
are with not only the ability to identify signs and symptoms of methamphetamine use, 
but also with the ability to further educate their peers, work colleagues, and patients. 
Education prepares nurses to work within their scope of practice to treat disease, 
prevent disease, and promote health. This concept was used in the development and 
implementation of this study.  
This project was a unique approach to address a potential knowledge deficit 
regarding perinatal methamphetamine use among student nurses. Future projects and 
studies that emphasize additional teaching measures and strategies to further enhance 
knowledge and awareness need to be conducted in order to reduce the frequency of 
methamphetamine-related complications. Additional studies are necessary to measure 
the effectiveness of various teachings strategies.  
This study should also be replicated in additional venues outside of the 
medical arena as increased knowledge of methamphetamine and methamphetamine-
related complications can be useful in any setting. Future studies could be conducted 
at other university nursing schools and within other university departments, such as 
the Health and Human Performance department or Exercise Science department. In 
addition to the college setting, additional studies should also target high school 
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students because use of methamphetamine among high school students has 
contributed to the prevalence of the problem surrounding methamphetamine abuse in 
the United States.   
Methamphetamine continues to be a prevalent community problem. Nurses 
possess the ability to intervene by increasing public awareness. Presentations 
designed to increase knowledge among nurses on methamphetamine will equip nurses 
with the information to enhance awareness among the public, and ultimately, lead to a 
reduction in methamphetamine use.  
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Appendix A 
Informed Consent 
Purpose of the Study: This study involves research that has been previously reviewed 
regarding the effects of maternal methamphetamine use on maternal, fetal, and 
neonatal outcomes. An in-depth examination of the current literature has been 
completed and serves as the basis for this study. The purpose of this research project 
is to provide educational content on the effects of perinatal methamphetamine use on 
maternal and child outcomes to third level undergraduate nursing students in the 
maternity nursing course and to examine changes in students’ knowledge, attitudes, 
and understanding of the issues surrounding methamphetamine use. This study has 
been approved by the Institutional Review Board at the University of Tennessee at 
Chattanooga.  
 
Description of Procedures to be Followed: The methods and procedures employed in 
this study will consist of online PRE and POST surveys and the educational 
presentation. You will be asked to respond to a series of 30 questions on the survey 
instrument following this consent form. The PRE survey will consist of 25 content 
based questions as well as 5 demographic related questions. The content based 
questions presented in the PRE/POST surveys will address topics relating to the 
history, origin, and prevalence of methamphetamine, the definition of 
methamphetamine, the overall effects of methamphetamine, the impact of maternal 
methamphetamine use in pregnancy on maternal and child outcomes, and signs and 
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symptoms of methamphetamine use. The questions on the PRE survey will mirror 
those on the post-assessment. The POST survey will consist of 25 content based 
questions, 1 demographic related question, and 1 reflection question. Following 
completion of the PRE survey, you will be provided with educational content related 
to maternal methamphetamine use and the effects on child outcomes. Once the 
educational presentation has concluded, a POST survey will be distributed 
immediately following implementation of the educational program.  
 
Expected Time Required for Participation: The PRE survey will be made available 
for completion on September 6, 2016. The educational content will be presented on 
October 4, 2016. The POST survey will be distributed for completion immediately 
following the educational presentation. The PRE/POST surveys will require 
approximately 45-60 minutes to complete. Provision of educational content will 
require approximately 30-45 minutes. Participation is solely voluntary. You may 
withdraw from the study at any point in time. However, it is anticipated that you will 
participate throughout the entire course of the study as content provided in this study 
will be incorporated into the content structure of the maternal childbearing course.  
 
Risks/Benefits: The risks associated with this study are minimal to none. The only 
notable risk is discomfort related to the methamphetamine content or personal 
experience related to such. You will be provided with contact information for the 
University’s Counseling and Personal Development Center (423-425-4438) in the 
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event you feel the need to discuss issues raised by this study. There are many notable 
benefits anticipated from this study. The specific information provided in this study 
will benefit you as a nursing student by enhancing your knowledge about 
methamphetamine so that you are better prepared to inform others of the detrimental 
effects of methamphetamine in any case. This study will not only benefit you by 
contributing to your field of knowledge and enhancing your practice as a nurse but 
will also benefit society as a whole. You will be knowledgeable about 
methamphetamine and will be able to care for and further educate your parents on the 
effects of methamphetamine.  
 
Confidentiality: No identifiable participant information will be kept and all data will 
be analyzed collectively with no identification of individual participants. You, the 
student, will be asked to provide your UTC ID for the purpose of cross referencing 
PRE/POST data. However, all research records will be confidential. Any and all 
forms associated with the survey will be kept in a locked file in Dr. Cherry Guinn’s 
office in the UTC School of Nursing. In addition to the author of this project, Dr. 
Guinn and Dr. Holcombe, who are faculty members of the School of Nursing and 
members of this project committee, will solely have access to all data utilized and 
acquired in this study. All online responses collected will require password protected 
access and will be guarded using Qualtrics enhanced SSL encryption.  
 
Incentives: No incentives will be offered for participation nor will you be penalized 
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for choosing not to participate in the PRE/POST surveys. If you choose not to 
participate in the PRE/POST surveys, you will still be expected to participate in the 
class during which the methamphetamine-related content is presented to the students. 
You will also be expected to participate in the subsequent assignments/examinations 
at the discretion of the course instructor as part of the course structure, but your 
reflections/observations will be omitted from data analysis and/or inclusion in any 
presentation of the results. Your PRE/POST survey responses will not be reflected as 
a grade for NURS 3350.  
 
If you choose to participate, please complete the survey according to the directions 
provided. Participation is completely voluntary and all responses are confidential. If 
you become uncomfortable or wish to stop answering questions for any reason, you 
are free to stop taking the survey at any time during the process.  
You may get a copy of the finalized results and any reports once the data is analyzed. 
If you wish to have this information, please contact:  
 
Tina F. Nguyen  
Email Address: RJX263@mocs.utc.edu Phone Number: (423) 834-4794  
Thank you for your time and participation.  
 
Sincerely, Tina F. Nguyen, BSN student  
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If you have any questions about your rights as a participant in this research or if you 
feel you have been placed at risk, you may contact Dr. Amy Doolittle, Chair of the 
Institutional Review Board, at 423-425-4289. Additional contact information is 
available at www.utc.edu/irb.  
If you feel the need to talk to anyone about any issues raised by this survey, please 
contact University Counseling Services at 423-425-4438.  
 
By responding [YES] to the following question, I affirm that:  
 
I have read the study information described above. I voluntarily agree to participate in 
the study. I affirm that I am 18 years of age or older.  
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Appendix B 
PRE/POST Surveys 
PRE/POST Survey  
1 Which of the following most accurately describes the prevalence and severity of 
methamphetamine use as it relates specifically to the state of Tennessee? 
A. Top 15 
B. Top 2 
C. Top 3 
D. Top 10    
 
2. Methamphetamine is also known by various street names, including all of the 
following EXCEPT: 
A. Zoom 
B. Crank 
C. Speed 
D. Fire  
 
3. What is the most common ingredient in methamphetamine? 
A. Diphendydramine 
B. Furosemide 
C. Methylin 
D. Pseudoephedrine 
 
4. Additional ingredients that are essential to the process of manufacturing 
methamphetamine include which of the following: 
A. Lithium  
B. Mercury 
C. Magnesium 
D. Arsenic 
 
5. Under what category of drugs is methamphetamine classified as? 
A. Depressants 
B. Hallucinogens 
C. Opiates 
D. Stimulants 
 
6. The physiological and psychoactive effects of methamphetamine occur due to 
mechanisms  
that increase the levels of all the following neurotransmitters EXCEPT: 
A. Dopamine 
B. Serotonin 
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C. Epinephrine 
D. Norepinephrine 
 
7. This neurotransmitter is involved in reward, motivation, pleasure, and motor 
function. Increased levels in this neurotransmitter result in the sense of increased 
alertness and intense euphoria, effects that lead people to use methamphetamine. 
A. Dopamine 
B. Serotonin 
C. Epinephrine 
D. Norepinephrine 
 
8. The effects of methamphetamine use occur as a result of the drug’s effect on which 
primary body system? 
A. Cardiovascular/Circulatory System 
B. Nervous System 
C. Muscular/Skeletal System 
D. Respiratory System 
 
9. Pharmaceutical methamphetamine is still available legally and is prescribed, 
though infrequently, to treat all of the following except: 
A. Obesity 
B. Narcolepsy 
C. Constipation 
D. ADHD 
 
10. Methamphetamine causes which of the following acute short-term effects: 
A. Visual disturbances 
B. Increased hunger 
C. Decreased energy  
D. Increased sexual pleasure 
 
11. Additional acute short-term effects of methamphetamine use include which of the 
following? 
A. Decreased respirations 
B. Irregular heartbeat 
C. Low blood pressure 
D. Slightly low body temperature 
 
12. Methamphetamine causes which of the following chronic long-term effects?  
A. Hypersomnia 
B. Weight gain 
C. Hallucinations 
D. Memory loss 
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13. Effects due to secondary methamphetamine exposure include which of the 
following? 
A. Respiratory distress 
B. Seizure 
C. Stroke 
D. Pulmonary hypertension 
 
14. Methamphetamine often leads to consumption of increased doses in order to 
produce the same desired effects. This lends to the drug’s highly dangerous nature 
and is referred to as: 
A. Intoxication 
B. Addiction 
C. Withdrawal 
D. Tolerance 
 
15. In regards to the demographic characteristics that are unique to the population of 
methamphetamine users, current literature studies illustrate that methamphetamine-
using women are more likely to demonstrate which of the following: 
A. Nulliparous  
B. Married 
C. Older age 
D. Low socioeconomic status  
 
16. Common maternal complications that can occur as a result of maternal 
methamphetamine use in pregnancy include all of the following EXCEPT: 
A. Miscarriage 
B. Hypertension 
C. Pre-eclampsia 
D. Pre-term labor/birth 
 
17. Studies show that methamphetamine-abusing mothers are at risk of having 
seizures, which occur as a result of what? 
A. High blood pressure 
B. Rapid heart rate 
C. Low protein  
D. Uncontrolled body temperature 
 
18. Maternal methamphetamine use can lead to alterations in placental function, 
which ultimately compromises fetal development by: 
A. Increasing levels of methamphetamine in the fetus 
B. Decreasing available oxygen to the fetus 
C. Increasing carbon dioxide levels in fetus 
D. Increasing accumulation of meconium  
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19. The fetal hypoxemia secondary to maternal methamphetamine use is likely caused 
by: 
A. Angioinfarction 
B. Vasodilation 
C. Venous stenosis 
D. Vasoconstriction 
 
20. Common fetal complications that can occur as a result of maternal 
methamphetamine use include which of the following: 
A. Pre-term birth 
B. Large for gestational age 
C. Cleft lip and palate  
D. Hydrocephaly  
 
21. Neonates born to methamphetamine abusing mothers have been shown to display 
which of the following? 
A. Decreased head circumference 
B. Slightly increased birth weight 
C. Decreased lung capacity 
D. Increased length  
 
22. Additional neonatal complications of maternal methamphetamine use include 
which of the following? 
A. Increased birth weight 
B. Increased length 
C. Small for gestational age 
D. Shorter length 
 
23. Behaviors that may be observed in mothers who are using methamphetamine 
include which of the following: 
A. Excessive happiness 
B. Hypo-vigilance 
C. Obsessive Compulsive Disorder 
D. Paranoia 
 
24. What common physical manifestation is often an indicator of methamphetamine 
use? 
A. Contusions 
B. Dental caries 
C. Onychorrhexis 
D. Alopecia 
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25. Methamphetamine users often get the sensation that there are insects creeping on 
top of, or underneath, the skin. This causes the user to pick at or scratch the skin, 
which can create open sores. This common hallucination is commonly referred to as: 
A. Sensory stage 
B. Crawl phase 
C. Itch phenomenon 
D. Crank bug 
 
PRE Survey ONLY 
1. Have you ever been exposed to a presentation on methamphetamine use? 
A. Yes 
B. No 
C. Not sure 
D. Prefer not to answer 
 
2. Have you ever cared for a patient with methamphetamine overdose? 
A. Yes 
B. No 
C. Not sure 
D. Prefer not to answer 
 
3. Have you ever been educated or provided with specific information on the effects 
of methamphetamine in pregnancy? 
A. Yes 
B. No 
C. Not sure 
D. Prefer not to answer 
 
4. Have you ever known a family member or friend who has used methamphetamine? 
A. Yes 
B. No 
C. Not sure 
D. Prefer not to answer 
 
4a. If so, what was your relationship to this person? 
_____________________________________________________________________ 
 
5. I feel comfortable discussing methamphetamine-related topics with my peers. 
A. Strongly Agree 
B. Agree 
C. Neutral 
D. Disagree 
E. Strongly Disagree 
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POST Survey ONLY 
1. I feel comfortable discussing methamphetamine-related topics with my peers. 
A. Strongly Agree 
B. Agree 
C. Neutral 
D. Disagree 
E. Strongly Disagree 
 
Reflection  
1. How do you anticipate using this information in your future practice as a nurse? 
_____________________________________________________________________ 
 
 
 
 
